JP4152301B2 - Oil-in-water emulsion composition - Google Patents
Oil-in-water emulsion composition Download PDFInfo
- Publication number
- JP4152301B2 JP4152301B2 JP2003373589A JP2003373589A JP4152301B2 JP 4152301 B2 JP4152301 B2 JP 4152301B2 JP 2003373589 A JP2003373589 A JP 2003373589A JP 2003373589 A JP2003373589 A JP 2003373589A JP 4152301 B2 JP4152301 B2 JP 4152301B2
- Authority
- JP
- Japan
- Prior art keywords
- component
- oil
- gel
- acid
- water
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000000203 mixture Substances 0.000 title claims description 53
- 239000007764 o/w emulsion Substances 0.000 title claims description 22
- -1 acyl sulfonate Chemical compound 0.000 claims description 30
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 23
- 238000002156 mixing Methods 0.000 claims description 22
- 238000002360 preparation method Methods 0.000 claims description 22
- 239000002253 acid Substances 0.000 claims description 18
- 125000000217 alkyl group Chemical group 0.000 claims description 13
- 230000015572 biosynthetic process Effects 0.000 claims description 13
- 229910052799 carbon Inorganic materials 0.000 claims description 12
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 claims description 11
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 claims description 10
- 239000003945 anionic surfactant Substances 0.000 claims description 7
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 7
- 150000003839 salts Chemical class 0.000 claims description 7
- 230000007704 transition Effects 0.000 claims description 6
- 125000004432 carbon atom Chemical group C* 0.000 claims description 5
- 229960000735 docosanol Drugs 0.000 claims description 5
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 claims description 5
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 claims description 4
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 4
- 229910052783 alkali metal Inorganic materials 0.000 claims description 4
- 229910052784 alkaline earth metal Inorganic materials 0.000 claims description 4
- OGQYPPBGSLZBEG-UHFFFAOYSA-N dimethyl(dioctadecyl)azanium Chemical compound CCCCCCCCCCCCCCCCCC[N+](C)(C)CCCCCCCCCCCCCCCCCC OGQYPPBGSLZBEG-UHFFFAOYSA-N 0.000 claims description 4
- 125000002252 acyl group Chemical group 0.000 claims description 3
- 150000001340 alkali metals Chemical class 0.000 claims description 3
- 150000001342 alkaline earth metals Chemical class 0.000 claims description 3
- 150000001412 amines Chemical class 0.000 claims description 3
- 229920006395 saturated elastomer Polymers 0.000 claims description 3
- 150000004671 saturated fatty acids Chemical class 0.000 claims description 3
- 150000004670 unsaturated fatty acids Chemical group 0.000 claims description 3
- 239000000499 gel Substances 0.000 description 40
- 239000000284 extract Substances 0.000 description 34
- 239000003921 oil Substances 0.000 description 18
- 235000019198 oils Nutrition 0.000 description 18
- 230000000052 comparative effect Effects 0.000 description 13
- 239000004094 surface-active agent Substances 0.000 description 11
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N EtOH Substances CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 10
- 230000002087 whitening effect Effects 0.000 description 10
- 229920003169 water-soluble polymer Polymers 0.000 description 9
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerol Natural products OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 8
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical group OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 8
- 239000000126 substance Substances 0.000 description 8
- 229910002091 carbon monoxide Inorganic materials 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- 239000012071 phase Substances 0.000 description 7
- 239000002585 base Substances 0.000 description 6
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 6
- 239000003795 chemical substances by application Substances 0.000 description 5
- 238000013329 compounding Methods 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 239000000839 emulsion Substances 0.000 description 5
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 5
- 229920002472 Starch Polymers 0.000 description 4
- 239000006096 absorbing agent Substances 0.000 description 4
- 150000007513 acids Chemical class 0.000 description 4
- 239000008346 aqueous phase Substances 0.000 description 4
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 4
- 229920002678 cellulose Polymers 0.000 description 4
- 239000001913 cellulose Substances 0.000 description 4
- 239000002537 cosmetic Substances 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 238000011156 evaluation Methods 0.000 description 4
- 150000004665 fatty acids Chemical group 0.000 description 4
- 238000009472 formulation Methods 0.000 description 4
- 235000011187 glycerol Nutrition 0.000 description 4
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 4
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 4
- 229960004889 salicylic acid Drugs 0.000 description 4
- 235000019698 starch Nutrition 0.000 description 4
- IZZIWIAOVZOBLF-UHFFFAOYSA-N 5-methoxysalicylic acid Chemical compound COC1=CC=C(O)C(C(O)=O)=C1 IZZIWIAOVZOBLF-UHFFFAOYSA-N 0.000 description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 229930182558 Sterol Natural products 0.000 description 3
- 150000001298 alcohols Chemical class 0.000 description 3
- 125000003545 alkoxy group Chemical group 0.000 description 3
- OGBUMNBNEWYMNJ-UHFFFAOYSA-N batilol Chemical compound CCCCCCCCCCCCCCCCCCOCC(O)CO OGBUMNBNEWYMNJ-UHFFFAOYSA-N 0.000 description 3
- 235000012000 cholesterol Nutrition 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 238000002844 melting Methods 0.000 description 3
- 230000008018 melting Effects 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 3
- 239000008107 starch Substances 0.000 description 3
- 150000003432 sterols Chemical class 0.000 description 3
- 235000003702 sterols Nutrition 0.000 description 3
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- HJIAMFHSAAEUKR-UHFFFAOYSA-N (2-hydroxyphenyl)-phenylmethanone Chemical compound OC1=CC=CC=C1C(=O)C1=CC=CC=C1 HJIAMFHSAAEUKR-UHFFFAOYSA-N 0.000 description 2
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 description 2
- ULQISTXYYBZJSJ-UHFFFAOYSA-N 12-hydroxyoctadecanoic acid Chemical compound CCCCCCC(O)CCCCCCCCCCC(O)=O ULQISTXYYBZJSJ-UHFFFAOYSA-N 0.000 description 2
- WNWHHMBRJJOGFJ-UHFFFAOYSA-N 16-methylheptadecan-1-ol Chemical compound CC(C)CCCCCCCCCCCCCCCO WNWHHMBRJJOGFJ-UHFFFAOYSA-N 0.000 description 2
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 2
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 2
- LTQRFSDXNWHXKQ-UHFFFAOYSA-N 2-[methyl(octadecanoyl)amino]ethanesulfonic acid Chemical class CCCCCCCCCCCCCCCCCC(=O)N(C)CCS(O)(=O)=O LTQRFSDXNWHXKQ-UHFFFAOYSA-N 0.000 description 2
- SVTBMSDMJJWYQN-UHFFFAOYSA-N 2-methylpentane-2,4-diol Chemical compound CC(O)CC(C)(C)O SVTBMSDMJJWYQN-UHFFFAOYSA-N 0.000 description 2
- MRIXVKKOHPQOFK-UHFFFAOYSA-N 4-methoxysalicylic acid Chemical compound COC1=CC=C(C(O)=O)C(O)=C1 MRIXVKKOHPQOFK-UHFFFAOYSA-N 0.000 description 2
- 244000144730 Amygdalus persica Species 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 239000005711 Benzoic acid Substances 0.000 description 2
- 239000004215 Carbon black (E152) Substances 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- 235000006040 Prunus persica var persica Nutrition 0.000 description 2
- 235000019484 Rapeseed oil Nutrition 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- RWZYAGGXGHYGMB-UHFFFAOYSA-N anthranilic acid Chemical compound NC1=CC=CC=C1C(O)=O RWZYAGGXGHYGMB-UHFFFAOYSA-N 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 229960000271 arbutin Drugs 0.000 description 2
- CUFNKYGDVFVPHO-UHFFFAOYSA-N azulene Chemical compound C1=CC=CC2=CC=CC2=C1 CUFNKYGDVFVPHO-UHFFFAOYSA-N 0.000 description 2
- 235000010233 benzoic acid Nutrition 0.000 description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 description 2
- 229960000541 cetyl alcohol Drugs 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- UKMSUNONTOPOIO-UHFFFAOYSA-N docosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- 235000020673 eicosapentaenoic acid Nutrition 0.000 description 2
- 239000010696 ester oil Substances 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 229920000591 gum Polymers 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 229930195733 hydrocarbon Natural products 0.000 description 2
- 150000002430 hydrocarbons Chemical class 0.000 description 2
- 230000001771 impaired effect Effects 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 229940069445 licorice extract Drugs 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- VAMXMNNIEUEQDV-UHFFFAOYSA-N methyl anthranilate Chemical compound COC(=O)C1=CC=CC=C1N VAMXMNNIEUEQDV-UHFFFAOYSA-N 0.000 description 2
- 239000002736 nonionic surfactant Substances 0.000 description 2
- OQILCOQZDHPEAZ-UHFFFAOYSA-N octyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OCCCCCCCC OQILCOQZDHPEAZ-UHFFFAOYSA-N 0.000 description 2
- 239000008385 outer phase Substances 0.000 description 2
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 229920001296 polysiloxane Polymers 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 229920002545 silicone oil Polymers 0.000 description 2
- HLZKNKRTKFSKGZ-UHFFFAOYSA-N tetradecan-1-ol Chemical compound CCCCCCCCCCCCCCO HLZKNKRTKFSKGZ-UHFFFAOYSA-N 0.000 description 2
- 239000006097 ultraviolet radiation absorber Substances 0.000 description 2
- NOOLISFMXDJSKH-KXUCPTDWSA-N (-)-Menthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O NOOLISFMXDJSKH-KXUCPTDWSA-N 0.000 description 1
- KZJWDPNRJALLNS-VPUBHVLGSA-N (-)-beta-Sitosterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@@](C)([C@H]([C@H](CC[C@@H](C(C)C)CC)C)CC4)CC3)CC=2)CC1 KZJWDPNRJALLNS-VPUBHVLGSA-N 0.000 description 1
- BQPPJGMMIYJVBR-UHFFFAOYSA-N (10S)-3c-Acetoxy-4.4.10r.13c.14t-pentamethyl-17c-((R)-1.5-dimethyl-hexen-(4)-yl)-(5tH)-Delta8-tetradecahydro-1H-cyclopenta[a]phenanthren Natural products CC12CCC(OC(C)=O)C(C)(C)C1CCC1=C2CCC2(C)C(C(CCC=C(C)C)C)CCC21C BQPPJGMMIYJVBR-UHFFFAOYSA-N 0.000 description 1
- CSVWWLUMXNHWSU-UHFFFAOYSA-N (22E)-(24xi)-24-ethyl-5alpha-cholest-22-en-3beta-ol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(CC)C(C)C)C1(C)CC2 CSVWWLUMXNHWSU-UHFFFAOYSA-N 0.000 description 1
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- DVSZKTAMJJTWFG-SKCDLICFSA-N (2e,4e,6e,8e,10e,12e)-docosa-2,4,6,8,10,12-hexaenoic acid Chemical compound CCCCCCCCC\C=C\C=C\C=C\C=C\C=C\C=C\C(O)=O DVSZKTAMJJTWFG-SKCDLICFSA-N 0.000 description 1
- DSEKYWAQQVUQTP-XEWMWGOFSA-N (2r,4r,4as,6as,6as,6br,8ar,12ar,14as,14bs)-2-hydroxy-4,4a,6a,6b,8a,11,11,14a-octamethyl-2,4,5,6,6a,7,8,9,10,12,12a,13,14,14b-tetradecahydro-1h-picen-3-one Chemical compound C([C@H]1[C@]2(C)CC[C@@]34C)C(C)(C)CC[C@]1(C)CC[C@]2(C)[C@H]4CC[C@@]1(C)[C@H]3C[C@@H](O)C(=O)[C@@H]1C DSEKYWAQQVUQTP-XEWMWGOFSA-N 0.000 description 1
- CHGIKSSZNBCNDW-UHFFFAOYSA-N (3beta,5alpha)-4,4-Dimethylcholesta-8,24-dien-3-ol Natural products CC12CCC(O)C(C)(C)C1CCC1=C2CCC2(C)C(C(CCC=C(C)C)C)CCC21 CHGIKSSZNBCNDW-UHFFFAOYSA-N 0.000 description 1
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 1
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 description 1
- TUSDEZXZIZRFGC-UHFFFAOYSA-N 1-O-galloyl-3,6-(R)-HHDP-beta-D-glucose Natural products OC1C(O2)COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC1C(O)C2OC(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-UHFFFAOYSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- HBXWUCXDUUJDRB-UHFFFAOYSA-N 1-octadecoxyoctadecane Chemical compound CCCCCCCCCCCCCCCCCCOCCCCCCCCCCCCCCCCCC HBXWUCXDUUJDRB-UHFFFAOYSA-N 0.000 description 1
- FRPZMMHWLSIFAZ-UHFFFAOYSA-N 10-undecenoic acid Chemical compound OC(=O)CCCCCCCCC=C FRPZMMHWLSIFAZ-UHFFFAOYSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- 229940114072 12-hydroxystearic acid Drugs 0.000 description 1
- LGEZTMRIZWCDLW-UHFFFAOYSA-N 14-methylpentadecyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCCC(C)C LGEZTMRIZWCDLW-UHFFFAOYSA-N 0.000 description 1
- XYTLYKGXLMKYMV-UHFFFAOYSA-N 14alpha-methylzymosterol Natural products CC12CCC(O)CC1CCC1=C2CCC2(C)C(C(CCC=C(C)C)C)CCC21C XYTLYKGXLMKYMV-UHFFFAOYSA-N 0.000 description 1
- BFPYWIDHMRZLRN-UHFFFAOYSA-N 17alpha-ethynyl estradiol Natural products OC1=CC=C2C3CCC(C)(C(CC4)(O)C#C)C4C3CCC2=C1 BFPYWIDHMRZLRN-UHFFFAOYSA-N 0.000 description 1
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 description 1
- JPWUIQIFCDAWQX-UHFFFAOYSA-N 2,3-dihydroxypropyl 2-ethylhexanoate Chemical compound CCCCC(CC)C(=O)OCC(O)CO JPWUIQIFCDAWQX-UHFFFAOYSA-N 0.000 description 1
- ZXDDPOHVAMWLBH-UHFFFAOYSA-N 2,4-Dihydroxybenzophenone Chemical compound OC1=CC(O)=CC=C1C(=O)C1=CC=CC=C1 ZXDDPOHVAMWLBH-UHFFFAOYSA-N 0.000 description 1
- JHDNFMVFXUETMC-UHFFFAOYSA-N 2-(2H-benzotriazol-4-yl)-4-methylphenol Chemical compound CC1=CC=C(O)C(C=2C=3N=NNC=3C=CC=2)=C1 JHDNFMVFXUETMC-UHFFFAOYSA-N 0.000 description 1
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 1
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 description 1
- 229940058020 2-amino-2-methyl-1-propanol Drugs 0.000 description 1
- MAFNOSKKQNVHRN-UHFFFAOYSA-N 2-hydroxy-3-methoxybenzoic acid Chemical compound OC1=C(C(=O)O)C=CC=C1OC.COC1=C(C(C(=O)O)=CC=C1)O MAFNOSKKQNVHRN-UHFFFAOYSA-N 0.000 description 1
- JUIYTAQAHOONSH-UHFFFAOYSA-N 2-hydroxy-4-propan-2-yloxybenzoic acid Chemical compound CC(C)OC1=CC=C(C(O)=O)C(O)=C1 JUIYTAQAHOONSH-UHFFFAOYSA-N 0.000 description 1
- UZJTWVRKIZXIIS-UHFFFAOYSA-N 2-hydroxy-4-propoxybenzoic acid Chemical compound OC1=C(C(=O)O)C=CC(=C1)OCCC.C(CC)OC=1C=C(C(C(=O)O)=CC1)O UZJTWVRKIZXIIS-UHFFFAOYSA-N 0.000 description 1
- AAUQLHHARJUJEH-UHFFFAOYSA-N 2-hydroxy-5-methoxybenzoic acid Natural products COC1=CC=CC(O)=C1C(O)=O AAUQLHHARJUJEH-UHFFFAOYSA-N 0.000 description 1
- WSSJONWNBBTCMG-UHFFFAOYSA-N 2-hydroxybenzoic acid (3,3,5-trimethylcyclohexyl) ester Chemical compound C1C(C)(C)CC(C)CC1OC(=O)C1=CC=CC=C1O WSSJONWNBBTCMG-UHFFFAOYSA-N 0.000 description 1
- WSRXLNLZLUNDKZ-UHFFFAOYSA-N 2-octadecanoyloxyethanesulfonic acid Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCS(O)(=O)=O WSRXLNLZLUNDKZ-UHFFFAOYSA-N 0.000 description 1
- XATHTZNVYDUDGS-UHFFFAOYSA-N 2-octadecylpropane-1,2,3-triol Chemical compound CCCCCCCCCCCCCCCCCCC(O)(CO)CO XATHTZNVYDUDGS-UHFFFAOYSA-N 0.000 description 1
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 description 1
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
- ADLFDNOTASDSPT-UHFFFAOYSA-N 2-tetradecanoyloxyethanesulfonic acid Chemical compound CCCCCCCCCCCCCC(=O)OCCS(O)(=O)=O ADLFDNOTASDSPT-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- KLEXDBGYSOIREE-UHFFFAOYSA-N 24xi-n-propylcholesterol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CCC)C(C)C)C1(C)CC2 KLEXDBGYSOIREE-UHFFFAOYSA-N 0.000 description 1
- CGPUDMDPOYTNKC-UHFFFAOYSA-N 3-ethoxy-2-hydroxybenzoic acid Chemical compound OC1=C(C(=O)O)C=CC=C1OCC.C(C)OC1=C(C(C(=O)O)=CC=C1)O CGPUDMDPOYTNKC-UHFFFAOYSA-N 0.000 description 1
- FPTJELQXIUUCEY-UHFFFAOYSA-N 3beta-Hydroxy-lanostan Natural products C1CC2C(C)(C)C(O)CCC2(C)C2C1C1(C)CCC(C(C)CCCC(C)C)C1(C)CC2 FPTJELQXIUUCEY-UHFFFAOYSA-N 0.000 description 1
- ZQXRINMCMHCYBD-UHFFFAOYSA-N 4-(2-ethylhexoxy)-4-oxobutanoic acid Chemical compound CCCCC(CC)COC(=O)CCC(O)=O ZQXRINMCMHCYBD-UHFFFAOYSA-N 0.000 description 1
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 description 1
- MOMKYJPSVWEWPM-UHFFFAOYSA-N 4-(chloromethyl)-2-(4-methylphenyl)-1,3-thiazole Chemical compound C1=CC(C)=CC=C1C1=NC(CCl)=CS1 MOMKYJPSVWEWPM-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- OLNUYDFPFSYWJG-UHFFFAOYSA-N 5-ethoxy-2-hydroxybenzoic acid Chemical compound OC1=C(C(=O)O)C=C(C=C1)OCC.C(C)OC1=CC=C(C(C(=O)O)=C1)O OLNUYDFPFSYWJG-UHFFFAOYSA-N 0.000 description 1
- RDBLNMQDEWOUIB-UHFFFAOYSA-N 5-methyl-2-phenyl-1,3-benzoxazole Chemical compound N=1C2=CC(C)=CC=C2OC=1C1=CC=CC=C1 RDBLNMQDEWOUIB-UHFFFAOYSA-N 0.000 description 1
- ODHCTXKNWHHXJC-VKHMYHEASA-N 5-oxo-L-proline Chemical compound OC(=O)[C@@H]1CCC(=O)N1 ODHCTXKNWHHXJC-VKHMYHEASA-N 0.000 description 1
- GZJLLYHBALOKEX-UHFFFAOYSA-N 6-Ketone, O18-Me-Ussuriedine Natural products CC=CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O GZJLLYHBALOKEX-UHFFFAOYSA-N 0.000 description 1
- ODMZDMMTKHXXKA-QXMHVHEDSA-N 8-methylnonyl (z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCCCCCCCC(C)C ODMZDMMTKHXXKA-QXMHVHEDSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- QGXLVXZRPRRCRP-IDIVVRGQSA-L Adenosine 5'-phosphate disodium Chemical compound [Na+].[Na+].C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP([O-])([O-])=O)[C@@H](O)[C@H]1O QGXLVXZRPRRCRP-IDIVVRGQSA-L 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- 235000019489 Almond oil Nutrition 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- ATRRKUHOCOJYRX-UHFFFAOYSA-N Ammonium bicarbonate Chemical compound [NH4+].OC([O-])=O ATRRKUHOCOJYRX-UHFFFAOYSA-N 0.000 description 1
- 229910000013 Ammonium bicarbonate Inorganic materials 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 235000021357 Behenic acid Nutrition 0.000 description 1
- 241001474374 Blennius Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 102000011632 Caseins Human genes 0.000 description 1
- 108010076119 Caseins Proteins 0.000 description 1
- 235000005940 Centaurea cyanus Nutrition 0.000 description 1
- 240000004385 Centaurea cyanus Species 0.000 description 1
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- LPZCCMIISIBREI-MTFRKTCUSA-N Citrostadienol Natural products CC=C(CC[C@@H](C)[C@H]1CC[C@H]2C3=CC[C@H]4[C@H](C)[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)C LPZCCMIISIBREI-MTFRKTCUSA-N 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- 235000013162 Cocos nucifera Nutrition 0.000 description 1
- 244000060011 Cocos nucifera Species 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 240000008067 Cucumis sativus Species 0.000 description 1
- 235000010799 Cucumis sativus var sativus Nutrition 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- 235000017788 Cydonia oblonga Nutrition 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 1
- ARVGMISWLZPBCH-UHFFFAOYSA-N Dehydro-beta-sitosterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)CCC(CC)C(C)C)CCC33)C)C3=CC=C21 ARVGMISWLZPBCH-UHFFFAOYSA-N 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- IUMSDRXLFWAGNT-UHFFFAOYSA-N Dodecamethylcyclohexasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 IUMSDRXLFWAGNT-UHFFFAOYSA-N 0.000 description 1
- OVBJJZOQPCKUOR-UHFFFAOYSA-L EDTA disodium salt dihydrate Chemical compound O.O.[Na+].[Na+].[O-]C(=O)C[NH+](CC([O-])=O)CC[NH+](CC([O-])=O)CC([O-])=O OVBJJZOQPCKUOR-UHFFFAOYSA-L 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000195955 Equisetum hyemale Species 0.000 description 1
- BFPYWIDHMRZLRN-SLHNCBLASA-N Ethinyl estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 BFPYWIDHMRZLRN-SLHNCBLASA-N 0.000 description 1
- 239000001856 Ethyl cellulose Substances 0.000 description 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
- 241000975394 Evechinus chloroticus Species 0.000 description 1
- 239000001263 FEMA 3042 Substances 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- BKLIAINBCQPSOV-UHFFFAOYSA-N Gluanol Natural products CC(C)CC=CC(C)C1CCC2(C)C3=C(CCC12C)C4(C)CCC(O)C(C)(C)C4CC3 BKLIAINBCQPSOV-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- CMBYOWLFQAFZCP-UHFFFAOYSA-N Hexyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCCCCCC CMBYOWLFQAFZCP-UHFFFAOYSA-N 0.000 description 1
- 235000013719 Houttuynia cordata Nutrition 0.000 description 1
- 240000000691 Houttuynia cordata Species 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 description 1
- 229930064664 L-arginine Natural products 0.000 description 1
- 235000014852 L-arginine Nutrition 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine Chemical compound [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- LOPKHWOTGJIQLC-UHFFFAOYSA-N Lanosterol Natural products CC(CCC=C(C)C)C1CCC2(C)C3=C(CCC12C)C4(C)CCC(C)(O)C(C)(C)C4CC3 LOPKHWOTGJIQLC-UHFFFAOYSA-N 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- 229920000161 Locust bean gum Polymers 0.000 description 1
- 244000280244 Luffa acutangula Species 0.000 description 1
- 235000009814 Luffa aegyptiaca Nutrition 0.000 description 1
- 235000018330 Macadamia integrifolia Nutrition 0.000 description 1
- 235000003800 Macadamia tetraphylla Nutrition 0.000 description 1
- 240000000912 Macadamia tetraphylla Species 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 235000008708 Morus alba Nutrition 0.000 description 1
- 240000000249 Morus alba Species 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- KCFRUUYAXCDZNZ-UHFFFAOYSA-N N-dodecanoyltaurine Chemical class CCCCCCCCCCCC(=O)NCCS(O)(=O)=O KCFRUUYAXCDZNZ-UHFFFAOYSA-N 0.000 description 1
- LMIJIHJZVURGQK-UHFFFAOYSA-N N-stearoyltaurine Chemical class CCCCCCCCCCCCCCCCCC(=O)NCCS(O)(=O)=O LMIJIHJZVURGQK-UHFFFAOYSA-N 0.000 description 1
- XPZFMHCHEWYIGE-UHFFFAOYSA-N N-tetradecanoyltaurine Chemical class CCCCCCCCCCCCCC(=O)NCCS(O)(=O)=O XPZFMHCHEWYIGE-UHFFFAOYSA-N 0.000 description 1
- 241000772415 Neovison vison Species 0.000 description 1
- CAHGCLMLTWQZNJ-UHFFFAOYSA-N Nerifoliol Natural products CC12CCC(O)C(C)(C)C1CCC1=C2CCC2(C)C(C(CCC=C(C)C)C)CCC21C CAHGCLMLTWQZNJ-UHFFFAOYSA-N 0.000 description 1
- 239000000020 Nitrocellulose Substances 0.000 description 1
- YTFVRYKNXDADBI-UHFFFAOYSA-N O-Methylsinapic acid Natural products COC1=CC(C=CC(O)=O)=CC(OC)=C1OC YTFVRYKNXDADBI-UHFFFAOYSA-N 0.000 description 1
- ODKQDMMAGZCECG-UHFFFAOYSA-N OC1=C(C(=O)O)C=C(C=C1)OC.COC1=CC=C(C(C(=O)O)=C1)O Chemical compound OC1=C(C(=O)O)C=C(C=C1)OC.COC1=CC=C(C(C(=O)O)=C1)O ODKQDMMAGZCECG-UHFFFAOYSA-N 0.000 description 1
- XFVZUSDWCYAPIC-UHFFFAOYSA-N OC1=C(C(=O)O)C=C(C=C1)OCCC.C(CC)OC1=CC=C(C(C(=O)O)=C1)O Chemical compound OC1=C(C(=O)O)C=C(C=C1)OCCC.C(CC)OC1=CC=C(C(C(=O)O)=C1)O XFVZUSDWCYAPIC-UHFFFAOYSA-N 0.000 description 1
- SRWAPXUZTRIHPA-UHFFFAOYSA-N OC1=C(C(=O)O)C=CC(=C1)OC.COC=1C=C(C(C(=O)O)=CC1)O Chemical compound OC1=C(C(=O)O)C=CC(=C1)OC.COC=1C=C(C(C(=O)O)=CC1)O SRWAPXUZTRIHPA-UHFFFAOYSA-N 0.000 description 1
- GLQOAAFGHOGNJN-UHFFFAOYSA-N OC1=C(C(=O)O)C=CC(=C1)OCC.C(C)OC=1C=C(C(C(=O)O)=CC1)O Chemical compound OC1=C(C(=O)O)C=CC(=C1)OCC.C(C)OC=1C=C(C(C(=O)O)=CC1)O GLQOAAFGHOGNJN-UHFFFAOYSA-N 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- BPQQTUXANYXVAA-UHFFFAOYSA-N Orthosilicate Chemical compound [O-][Si]([O-])([O-])[O-] BPQQTUXANYXVAA-UHFFFAOYSA-N 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 241000237502 Ostreidae Species 0.000 description 1
- 241000736199 Paeonia Species 0.000 description 1
- 235000006484 Paeonia officinalis Nutrition 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Penta-digallate-beta-D-glucose Natural products OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 229920002873 Polyethylenimine Polymers 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 244000028344 Primula vulgaris Species 0.000 description 1
- 235000016311 Primula vulgaris Nutrition 0.000 description 1
- HDSBZMRLPLPFLQ-UHFFFAOYSA-N Propylene glycol alginate Chemical compound OC1C(O)C(OC)OC(C(O)=O)C1OC1C(O)C(O)C(C)C(C(=O)OCC(C)O)O1 HDSBZMRLPLPFLQ-UHFFFAOYSA-N 0.000 description 1
- 241000220317 Rosa Species 0.000 description 1
- 240000007651 Rubus glaucus Species 0.000 description 1
- 235000011034 Rubus glaucus Nutrition 0.000 description 1
- 235000009122 Rubus idaeus Nutrition 0.000 description 1
- 235000019485 Safflower oil Nutrition 0.000 description 1
- 235000002953 Saxifraga stolonifera Nutrition 0.000 description 1
- 244000288377 Saxifraga stolonifera Species 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 244000044822 Simmondsia californica Species 0.000 description 1
- 235000004433 Simmondsia californica Nutrition 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- 229920002385 Sodium hyaluronate Polymers 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 235000019486 Sunflower oil Nutrition 0.000 description 1
- 244000223014 Syzygium aromaticum Species 0.000 description 1
- 235000016639 Syzygium aromaticum Nutrition 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 1
- 241001122767 Theaceae Species 0.000 description 1
- 235000007303 Thymus vulgaris Nutrition 0.000 description 1
- 240000002657 Thymus vulgaris Species 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- ZQBINFHUKAWMGP-UHFFFAOYSA-N [3-hydroxy-2,2-bis(hydroxymethyl)propyl] hexanoate Chemical compound CCCCCC(=O)OCC(CO)(CO)CO ZQBINFHUKAWMGP-UHFFFAOYSA-N 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 235000010419 agar Nutrition 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- 239000008168 almond oil Substances 0.000 description 1
- 229940069521 aloe extract Drugs 0.000 description 1
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- CBTVGIZVANVGBH-UHFFFAOYSA-N aminomethyl propanol Chemical compound CC(C)(N)CO CBTVGIZVANVGBH-UHFFFAOYSA-N 0.000 description 1
- 235000012538 ammonium bicarbonate Nutrition 0.000 description 1
- 239000001099 ammonium carbonate Substances 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 239000002280 amphoteric surfactant Substances 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- BTFJIXJJCSYFAL-UHFFFAOYSA-N arachidyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 235000009697 arginine Nutrition 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 239000000305 astragalus gummifer gum Substances 0.000 description 1
- 239000003212 astringent agent Substances 0.000 description 1
- XNEFYCZVKIDDMS-UHFFFAOYSA-N avobenzone Chemical compound C1=CC(OC)=CC=C1C(=O)CC(=O)C1=CC=C(C(C)(C)C)C=C1 XNEFYCZVKIDDMS-UHFFFAOYSA-N 0.000 description 1
- 235000021302 avocado oil Nutrition 0.000 description 1
- 239000008163 avocado oil Substances 0.000 description 1
- IWWCATWBROCMCW-UHFFFAOYSA-N batyl alcohol Natural products CCCCCCCCCCCCCCCCCCOC(O)CO IWWCATWBROCMCW-UHFFFAOYSA-N 0.000 description 1
- 229940116226 behenic acid Drugs 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- MJVXAPPOFPTTCA-UHFFFAOYSA-N beta-Sistosterol Natural products CCC(CCC(C)C1CCC2C3CC=C4C(C)C(O)CCC4(C)C3CCC12C)C(C)C MJVXAPPOFPTTCA-UHFFFAOYSA-N 0.000 description 1
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 description 1
- 239000003833 bile salt Substances 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 125000004106 butoxy group Chemical group [*]OC([H])([H])C([H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- 239000010495 camellia oil Substances 0.000 description 1
- 229960000846 camphor Drugs 0.000 description 1
- 229930008380 camphor Natural products 0.000 description 1
- KHAVLLBUVKBTBG-UHFFFAOYSA-N caproleic acid Natural products OC(=O)CCCCCCCC=C KHAVLLBUVKBTBG-UHFFFAOYSA-N 0.000 description 1
- 150000001721 carbon Chemical group 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 229940008396 carrot extract Drugs 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 229920006317 cationic polymer Polymers 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 229940082500 cetostearyl alcohol Drugs 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 229960003260 chlorhexidine Drugs 0.000 description 1
- KXKPYJOVDUMHGS-OSRGNVMNSA-N chondroitin sulfate Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](OS(O)(=O)=O)[C@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](C(O)=O)O1 KXKPYJOVDUMHGS-OSRGNVMNSA-N 0.000 description 1
- 229940079840 cocoyl isethionate Drugs 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- 229960003067 cystine Drugs 0.000 description 1
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
- 229940105990 diglycerin Drugs 0.000 description 1
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 1
- QBSJHOGDIUQWTH-UHFFFAOYSA-N dihydrolanosterol Natural products CC(C)CCCC(C)C1CCC2(C)C3=C(CCC12C)C4(C)CCC(C)(O)C(C)(C)C4CC3 QBSJHOGDIUQWTH-UHFFFAOYSA-N 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- 229940113120 dipropylene glycol Drugs 0.000 description 1
- 235000020669 docosahexaenoic acid Nutrition 0.000 description 1
- KAUVQQXNCKESLC-UHFFFAOYSA-N docosahexaenoic acid (DHA) Natural products COC(=O)C(C)NOCC1=CC=CC=C1 KAUVQQXNCKESLC-UHFFFAOYSA-N 0.000 description 1
- LQZZUXJYWNFBMV-UHFFFAOYSA-N dodecan-1-ol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 229960005135 eicosapentaenoic acid Drugs 0.000 description 1
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 229960003720 enoxolone Drugs 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 229930182833 estradiol Natural products 0.000 description 1
- 229960005309 estradiol Drugs 0.000 description 1
- 229960002568 ethinylestradiol Drugs 0.000 description 1
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 1
- HPMLGOFBKNGJAM-ONEGZZNKSA-N ethyl (e)-3-(1h-imidazol-5-yl)prop-2-enoate Chemical compound CCOC(=O)\C=C\C1=CN=CN1 HPMLGOFBKNGJAM-ONEGZZNKSA-N 0.000 description 1
- 235000019325 ethyl cellulose Nutrition 0.000 description 1
- 229920001249 ethyl cellulose Polymers 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 229940007062 eucalyptus extract Drugs 0.000 description 1
- 229940072117 fennel extract Drugs 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- FODTZLFLDFKIQH-FSVGXZBPSA-N gamma-Oryzanol (TN) Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)O[C@@H]2C([C@@H]3CC[C@H]4[C@]5(C)CC[C@@H]([C@@]5(C)CC[C@@]54C[C@@]53CC2)[C@H](C)CCC=C(C)C)(C)C)=C1 FODTZLFLDFKIQH-FSVGXZBPSA-N 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 229960002442 glucosamine Drugs 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229960005150 glycerol Drugs 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 239000001685 glycyrrhizic acid Substances 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 239000010440 gypsum Substances 0.000 description 1
- 229910052602 gypsum Inorganic materials 0.000 description 1
- KWLMIXQRALPRBC-UHFFFAOYSA-L hectorite Chemical compound [Li+].[OH-].[OH-].[Na+].[Mg+2].O1[Si]2([O-])O[Si]1([O-])O[Si]([O-])(O1)O[Si]1([O-])O2 KWLMIXQRALPRBC-UHFFFAOYSA-L 0.000 description 1
- 229910000271 hectorite Inorganic materials 0.000 description 1
- ACGUYXCXAPNIKK-UHFFFAOYSA-N hexachlorophene Chemical compound OC1=C(Cl)C=C(Cl)C(Cl)=C1CC1=C(O)C(Cl)=CC(Cl)=C1Cl ACGUYXCXAPNIKK-UHFFFAOYSA-N 0.000 description 1
- 229960004068 hexachlorophene Drugs 0.000 description 1
- DWMMZQMXUWUJME-UHFFFAOYSA-N hexadecyl octanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)CCCCCCC DWMMZQMXUWUJME-UHFFFAOYSA-N 0.000 description 1
- 229940100463 hexyl laurate Drugs 0.000 description 1
- 229940051250 hexylene glycol Drugs 0.000 description 1
- 229960004881 homosalate Drugs 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 239000008309 hydrophilic cream Substances 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 125000002510 isobutoxy group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])O* 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 229940078545 isocetyl stearate Drugs 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 125000003253 isopropoxy group Chemical group [H]C([H])([H])C([H])(O*)C([H])([H])[H] 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 229940093629 isopropyl isostearate Drugs 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 229940058690 lanosterol Drugs 0.000 description 1
- CAHGCLMLTWQZNJ-RGEKOYMOSA-N lanosterol Chemical compound C([C@]12C)C[C@@H](O)C(C)(C)[C@H]1CCC1=C2CC[C@]2(C)[C@H]([C@H](CCC=C(C)C)C)CC[C@@]21C CAHGCLMLTWQZNJ-RGEKOYMOSA-N 0.000 description 1
- 229940094522 laponite Drugs 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 1
- 239000000944 linseed oil Substances 0.000 description 1
- 235000021388 linseed oil Nutrition 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- XCOBTUNSZUJCDH-UHFFFAOYSA-B lithium magnesium sodium silicate Chemical compound [Li+].[Li+].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[Na+].[Na+].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3 XCOBTUNSZUJCDH-UHFFFAOYSA-B 0.000 description 1
- 235000010420 locust bean gum Nutrition 0.000 description 1
- 239000000711 locust bean gum Substances 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N malic acid Chemical compound OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- 229960002160 maltose Drugs 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 1
- 229940102398 methyl anthranilate Drugs 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 229940071146 myristoyl isethionate Drugs 0.000 description 1
- 229940043348 myristyl alcohol Drugs 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 229920001220 nitrocellulos Polymers 0.000 description 1
- 239000010466 nut oil Substances 0.000 description 1
- UVPGECJLXBGLDW-UHFFFAOYSA-N octadecan-7-ol Chemical compound CCCCCCCCCCCC(O)CCCCCC UVPGECJLXBGLDW-UHFFFAOYSA-N 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- HMMGMWAXVFQUOA-UHFFFAOYSA-N octamethylcyclotetrasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 HMMGMWAXVFQUOA-UHFFFAOYSA-N 0.000 description 1
- KSCKTBJJRVPGKM-UHFFFAOYSA-N octan-1-olate;titanium(4+) Chemical compound [Ti+4].CCCCCCCC[O-].CCCCCCCC[O-].CCCCCCCC[O-].CCCCCCCC[O-] KSCKTBJJRVPGKM-UHFFFAOYSA-N 0.000 description 1
- 229940060184 oil ingredients Drugs 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- 229940055577 oleyl alcohol Drugs 0.000 description 1
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- DXGLGDHPHMLXJC-UHFFFAOYSA-N oxybenzone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1 DXGLGDHPHMLXJC-UHFFFAOYSA-N 0.000 description 1
- 235000020636 oyster Nutrition 0.000 description 1
- 229940056211 paraffin Drugs 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 229960005323 phenoxyethanol Drugs 0.000 description 1
- 235000011007 phosphoric acid Nutrition 0.000 description 1
- 239000003504 photosensitizing agent Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 description 1
- 229920002432 poly(vinyl methyl ether) polymer Polymers 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- 229920000120 polyethyl acrylate Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920002503 polyoxyethylene-polyoxypropylene Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 235000007686 potassium Nutrition 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 235000011118 potassium hydroxide Nutrition 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- NEOZOXKVMDBOSG-UHFFFAOYSA-N propan-2-yl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OC(C)C NEOZOXKVMDBOSG-UHFFFAOYSA-N 0.000 description 1
- ULWHHBHJGPPBCO-UHFFFAOYSA-N propane-1,1-diol Chemical compound CCC(O)O ULWHHBHJGPPBCO-UHFFFAOYSA-N 0.000 description 1
- 235000010409 propane-1,2-diol alginate Nutrition 0.000 description 1
- 239000000770 propane-1,2-diol alginate Substances 0.000 description 1
- 125000002572 propoxy group Chemical group [*]OC([H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229960004063 propylene glycol Drugs 0.000 description 1
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 1
- 229960004172 pyridoxine hydrochloride Drugs 0.000 description 1
- 235000019171 pyridoxine hydrochloride Nutrition 0.000 description 1
- 239000011764 pyridoxine hydrochloride Substances 0.000 description 1
- 229940079889 pyrrolidonecarboxylic acid Drugs 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 235000005713 safflower oil Nutrition 0.000 description 1
- 239000003813 safflower oil Substances 0.000 description 1
- 229940112950 sage extract Drugs 0.000 description 1
- 235000020752 sage extract Nutrition 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- 239000003352 sequestering agent Substances 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 229920002050 silicone resin Polymers 0.000 description 1
- 229920002379 silicone rubber Polymers 0.000 description 1
- 239000004945 silicone rubber Substances 0.000 description 1
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 1
- 235000015500 sitosterol Nutrition 0.000 description 1
- 229950005143 sitosterol Drugs 0.000 description 1
- NLQLSVXGSXCXFE-UHFFFAOYSA-N sitosterol Natural products CC=C(/CCC(C)C1CC2C3=CCC4C(C)C(O)CCC4(C)C3CCC2(C)C1)C(C)C NLQLSVXGSXCXFE-UHFFFAOYSA-N 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 229940037001 sodium edetate Drugs 0.000 description 1
- 229940010747 sodium hyaluronate Drugs 0.000 description 1
- 235000011121 sodium hydroxide Nutrition 0.000 description 1
- 239000001540 sodium lactate Substances 0.000 description 1
- 229940005581 sodium lactate Drugs 0.000 description 1
- 235000011088 sodium lactate Nutrition 0.000 description 1
- 235000019983 sodium metaphosphate Nutrition 0.000 description 1
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 description 1
- 235000019830 sodium polyphosphate Nutrition 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 1
- KKDONKAYVYTWGY-UHFFFAOYSA-M sodium;2-(methylamino)ethanesulfonate Chemical compound [Na+].CNCCS([O-])(=O)=O KKDONKAYVYTWGY-UHFFFAOYSA-M 0.000 description 1
- KJCLYACXIWMFCC-UHFFFAOYSA-M sodium;5-benzoyl-4-hydroxy-2-methoxybenzenesulfonate Chemical compound [Na+].C1=C(S([O-])(=O)=O)C(OC)=CC(O)=C1C(=O)C1=CC=CC=C1 KJCLYACXIWMFCC-UHFFFAOYSA-M 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 229940031439 squalene Drugs 0.000 description 1
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 229940012831 stearyl alcohol Drugs 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- WPLOVIFNBMNBPD-ATHMIXSHSA-N subtilin Chemical compound CC1SCC(NC2=O)C(=O)NC(CC(N)=O)C(=O)NC(C(=O)NC(CCCCN)C(=O)NC(C(C)CC)C(=O)NC(=C)C(=O)NC(CCCCN)C(O)=O)CSC(C)C2NC(=O)C(CC(C)C)NC(=O)C1NC(=O)C(CCC(N)=O)NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C1NC(=O)C(=C/C)/NC(=O)C(CCC(N)=O)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C2NC(=O)CNC(=O)C3CCCN3C(=O)C(NC(=O)C3NC(=O)C(CC(C)C)NC(=O)C(=C)NC(=O)C(CCC(O)=O)NC(=O)C(NC(=O)C(CCCCN)NC(=O)C(N)CC=4C5=CC=CC=C5NC=4)CSC3)C(C)SC2)C(C)C)C(C)SC1)CC1=CC=CC=C1 WPLOVIFNBMNBPD-ATHMIXSHSA-N 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000002600 sunflower oil Substances 0.000 description 1
- LRBQNJMCXXYXIU-NRMVVENXSA-N tannic acid Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-NRMVVENXSA-N 0.000 description 1
- 229920002258 tannic acid Polymers 0.000 description 1
- 229940033123 tannic acid Drugs 0.000 description 1
- 235000015523 tannic acid Nutrition 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 229940104261 taurate Drugs 0.000 description 1
- 229960003080 taurine Drugs 0.000 description 1
- 230000002123 temporal effect Effects 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 1
- 210000001541 thymus gland Anatomy 0.000 description 1
- 239000001585 thymus vulgaris Substances 0.000 description 1
- LOIYMIARKYCTBW-OWOJBTEDSA-N trans-urocanic acid Chemical compound OC(=O)\C=C\C1=CNC=N1 LOIYMIARKYCTBW-OWOJBTEDSA-N 0.000 description 1
- LOIYMIARKYCTBW-UHFFFAOYSA-N trans-urocanic acid Natural products OC(=O)C=CC1=CNC=N1 LOIYMIARKYCTBW-UHFFFAOYSA-N 0.000 description 1
- PMBRBOODEWULOI-UHFFFAOYSA-N trichloromethanide Chemical compound Cl[C-](Cl)Cl PMBRBOODEWULOI-UHFFFAOYSA-N 0.000 description 1
- VLPFTAMPNXLGLX-UHFFFAOYSA-N trioctanoin Chemical compound CCCCCCCC(=O)OCC(OC(=O)CCCCCCC)COC(=O)CCCCCCC VLPFTAMPNXLGLX-UHFFFAOYSA-N 0.000 description 1
- 229960002703 undecylenic acid Drugs 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
- 239000001243 zingiber officinale rosc. root absolute Substances 0.000 description 1
Description
本発明は皮膚外用剤として用いられる水中油型乳化組成物に関する。さらに詳しくは美白効果に優れ、かつ経時安定性および使用性が良好な水中油型乳化組成物に関する。 The present invention relates to oil-in-water emulsified composition for use as a skin Hadagaiyo agent. More particularly, the present invention relates to an oil-in-water emulsion composition that is excellent in whitening effect and has good temporal stability and usability.
白く美しい肌を意味する「美白」は、皮膚外用剤、特に化粧料においては、最も重要なテーマの1つである。 “Whitening”, which means white and beautiful skin, is one of the most important themes in external preparations for skin, especially cosmetics.
この「美白」を目的にした化粧品には、美白成分として、例えばビタミンCやその誘導体、アルブチン等が配合されている。美白成分についての探索は近年、ますます盛んになっており、その成果の1つとして、美白効果に優れる成分としてアルコキシサリチル酸類が提案されている(特許文献1)。 In cosmetics intended for this “whitening”, as a whitening component, for example, vitamin C, its derivatives, arbutin and the like are blended. Searches for whitening components have become increasingly popular in recent years, and as one of the results, alkoxysalicylic acids have been proposed as components having an excellent whitening effect (Patent Document 1).
しかしながら、アルコキシサリチル酸類を水中油型乳化組成物に配合した場合、保存安定性、特に温度(高温・低温)安定性が悪く、経時で分離や離將を起こしやすいという問題があった。 However, when alkoxysalicylic acids are blended in an oil-in-water emulsion composition, there is a problem that storage stability, particularly temperature (high temperature / low temperature) stability, is poor, and separation or separation tends to occur over time.
なお、外相にα−ゲルを含む構成とすることにより使用性、高温安定性を高めた水中油型乳化組成物が本出願人により提案されている(特許文献2)が、アルコキシサリチル酸類を配合した場合の安定性についての考察・研究はされていない。 In addition, an oil-in-water emulsion composition having improved usability and high-temperature stability by including α-gel in the outer phase has been proposed by the present applicant (Patent Document 2), but it contains alkoxysalicylic acids. There has been no consideration or research on the stability of these cases.
本発明は、上記従来技術の問題点を解決するためになされたものであり、その目的は、アルコキシサリチル酸類を配合した系において経時での乳化安定性が良好で、しかも使用性に優れる水中油型乳化組成物を提供することにある。 The present invention has been made in order to solve the above-mentioned problems of the prior art, and its purpose is to provide an oil-in-water solution having good emulsification stability with time and excellent usability in a system containing alkoxysalicylic acids. It is in providing a type | mold emulsion composition.
上記課題を達成するために本発明は、下記(A)〜(E)成分を含み、かつ、下記条件(i)〜(iv)を満足する、水中油型乳化組成物を提供する。 In order to achieve the above object, the present invention provides an oil-in-water emulsion composition comprising the following components (A) to (E) and satisfying the following conditions (i) to (iv).
(A)成分: 下記一般式(I)で示されるアルコキシサリチル酸またはその塩。 Component (A): Alkoxysalicylic acid represented by the following general formula (I) or a salt thereof.
(式(I)中、Rは炭素原子数1〜6の低級アルキル基を示す)。 (In the formula (I), R represents a lower alkyl group having 1 to 6 carbon atoms ).
(B)成分: 下記一般式(II)で表される長鎖アシルスルホン酸塩型陰イオン性界面活性剤。 (B) Component: Long chain acyl sulfonate type anionic surfactant represented by the following general formula (II).
R1CO−a−(CH2)nSO3M1 (II) R 1 CO-a- (CH 2 ) n SO 3 M 1 (II)
(式(II)中、R1CO−は平均炭素原子数10〜22の飽和または不飽和の脂肪酸残基(アシル基)を示し;aは−O−または−NR2−(ただし、R2は水素原子、または炭素原子数1〜3のアルキル基を示す)を示し;M1は水素原子、アルカリ金属類、アルカリ土類金属類、アンモニウムまたは有機アミン類を示し;nは1〜3の整数を示す)。 (In the formula (II), R 1 CO— represents a saturated or unsaturated fatty acid residue (acyl group) having an average carbon number of 10 to 22; a represents —O— or —NR 2 — (where R 2 Represents a hydrogen atom or an alkyl group having 1 to 3 carbon atoms); M 1 represents a hydrogen atom, an alkali metal, an alkaline earth metal, ammonium or an organic amine; n represents 1 to 3 Indicates an integer).
(C)成分: 下記(C 1 )成分および(C 2 )成分。
(C 1 )成分:ステアリルアルコールおよび/またはベヘニルアルコール。
(C 2 )成分:直鎖または分岐鎖のアルキル鎖を有する、炭素原子数12〜22の高級脂肪族
(C) component: The following (C 1 ) component and (C 2 ) component.
Component (C 1 ): stearyl alcohol and / or behenyl alcohol.
(C 2) component: with a straight or branched alkyl chain, higher aliphatic carbon atoms 12 to 22
(D)成分: 水。 (D) Component: Water.
(E)成分: 油分。 (E) component: Oil content.
条件(i): (B)成分と(C 1 )成分と(D)成分とでゲルを形成し、形成されるゲルの転移温度が60℃以上である。 Condition (i): (B) forming a component and gel in the (C 1) component and the (D) component transition temperature of the gel formed is 60 ° C. or higher.
条件(ii): 上記ゲルを形成する(B)成分の配合量が、水中油型乳化組成物全量に対して0.1質量%以上1.0質量%未満である。 Condition (ii): The blending amount of the component (B) forming the gel is 0.1% by mass or more and less than 1.0% by mass with respect to the total amount of the oil-in-water emulsion composition.
条件(iii): 上記ゲルを形成する(B)成分と(C 1 )成分の配合量のモル比が1:3である。 Condition (iii): The molar ratio of the blending amount of the component (B) and the component (C 1 ) forming the gel is 1: 3.
条件(iv):ゲルの形成に関与しない(C 2 )成分または両親媒性物質を含有し、その配合量が水中油型乳化皮膚外用剤全量に対して0.98745〜3.50841質量%である。 Condition (iv): I do not want to participate in the formation of the gel (C 2) containing components or amphiphile, from 0.98745 to 3.50841 weight amount thereof is against the oil-in-water emulsion total amount of the skin treatment composition %.
また本発明は、クリーム状または乳液状皮膚外用剤である、上記水中油型乳化組成物を提供する。 The present invention also provides the oil-in-water emulsion composition, which is a creamy or milky skin external preparation.
本発明により、アルコキシサリチル酸またはその塩による優れた美白効果を生かしつつ、安定性および使用性の良好な水中油型乳化組成物が提供される。 The present invention, while taking excellent whitening effect by Arco key Shisarichiru acid or a salt thereof, good oil-in-water emulsion composition of the stability and usability is provided.
本発明で用いられる(A)成分のアルコキシサリチル酸は、下記一般式(I)で表される、サリチル酸の3位、4位または5位のいずれかの水素原子がアルコキシ基(−OR)で置換されたサリチル酸系化合物である。 The alkoxysalicylic acid of component (A) used in the present invention is represented by the following general formula (I), and the hydrogen atom at the 3-position, 4-position or 5-position of salicylic acid is substituted with an alkoxy group (—OR). Is a salicylic acid compound.
上記一般式(I)において、アルコキシ基(−OR)を構成するアルキル基(R)は、炭素原子数1〜6の低級アルキル基である。直鎖、分岐鎖のいずれも含む。具体的には、メチル基(対応するアルコキシ基−OR:メトキシ基)、エチル基(同:エトキシ基)、プロピル基(同:プロポキシ基)、イソプロピル基(同:イソプロポキシ基)、ブチル基(同:ブトキシ基)、イソブチル基(同:イソブトキシ基)等を挙げることができるが、これらに限定されるものでない。 In the general formula (I), the alkyl group constituting the alkoxy group (-OR) (R) is a lower alkyl group carbon atom number of 1-6. Both straight and branched chains are included. Specifically, a methyl group (corresponding alkoxy group-OR: methoxy group), ethyl group (same: ethoxy group), propyl group (same: propoxy group), isopropyl group (same: isopropoxy group), butyl group ( I.e., butoxy group) and isobutyl group (i.e., isobutoxy group), but are not limited thereto.
上記一般式(I)で表されるアルコキシサリチル酸としては、具体的には、3−メトキシサリチル酸(2-hydroxy-3-methoxybenzoic acid)、3−エトキシサリチル酸(2-hydroxy-3-ethoxybenzoic acid)、4−メトキシサリチル酸(2-hydroxy-4-methoxybenzoic acid)、4−エトキシサリチル酸(2-hydroxy-4-ethoxybenzoic acid)、4−プロポキシサリチル酸(2-hydroxy-4-propoxybenzoic acid)、4−イソプロキシサリチル酸(2-hydroxy-4-isopropoxybenzoic acid)、4−ブトキシプロキシサリチル酸(2-hydroxy-4-buthoxybenzoic acid)、5−メトキシサリチル酸(2-hydroxy-5-methoxybenzoic acid)、5−エトキシサリチル酸(2-hydroxy-5-ethoxybenzoic acid)、5−プロポキシサリチル酸(2-hydroxy-5-propoxybenzoic acid)等が挙げられる。 Specific examples of the alkoxysalicylic acid represented by the general formula (I) include 3-methoxysalicylic acid (2-hydroxy-3-methoxybenzoic acid), 3-ethoxysalicylic acid (2-hydroxy-3-ethoxybenzoic acid), 4-Methoxysalicylic acid (2-hydroxy-4-methoxybenzoic acid), 4-Ethoxysalicylic acid (2-hydroxy-4-ethoxybenzoic acid), 4-Propoxysalicylic acid (2-hydroxy-4-propoxybenzoic acid), 4-Isoproxysalicylic acid (2-hydroxy-4-isopropoxybenzoic acid), 4-butoxyproxysalicylic acid (2-hydroxy-4-buthoxybenzoic acid), 5-methoxysalicylic acid (2-hydroxy-5-methoxybenzoic acid), 5-ethoxysalicylic acid (2-hydroxy) -5-ethoxybenzoic acid), 5-propoxysalicylic acid (2-hydroxy-5-propoxybenzoic acid) and the like.
アルコキシサリチル酸は既知の物質であり、例えば、5−メトキシサリチル酸は"Beil"、10227に、4−メトキシサリチル酸は"Beil"、10379に、それぞれ記載されている方法で容易に合成することができる。またアルドリッチ(Aldrich)社(ドイツ)等からは試薬として市販されており、これを用いることも可能である。 Alkoxysalicylic acid is a known substance. For example, 5-methoxysalicylic acid can be easily synthesized by the methods described in “Beil” and 10227, and 4-methoxysalicylic acid in “Beil” and 10379, respectively. Further, it is commercially available as a reagent from Aldrich (Germany) and the like, and it is also possible to use it.
本発明乳化組成物に配合され得る、アルコキシサリチル酸は、その塩も含む。かかる塩の種類は、製薬学上許容され得る塩であれば特に限定されるものではなく、例えば、ナトリウム塩、カリウム塩等のアルカリ金属塩や、カルシウム塩等のアルカリ土類金属塩のほか、アンモニウム塩やアミノ酸塩等の塩が挙げられる。 Alkoxysalicylic acid that can be blended in the emulsion composition of the present invention includes a salt thereof. The type of the salt is not particularly limited as long as it is a pharmaceutically acceptable salt, for example, alkali metal salts such as sodium salt and potassium salt, alkaline earth metal salts such as calcium salt, Examples include salts such as ammonium salts and amino acid salts.
(A)成分は1種または2種以上を配合することができる。(A)成分の配合量は、皮膚外用剤の具体的な剤型や他の配合成分との兼ね合いに応じて、適宜選択されるべきものであり、特に限定されるものでないが、一般的には、剤全体に対して0.001〜20.0質量%が好ましく、特に好ましくは0.01〜10.0質量%である。0.001質量%未満では美白効果を十分に発揮させることが困難であり、一方、20.0質量%を超えて配合しても、配合量の増加に見合った美白効果の向上は認められ難く、かえってべたついた使用感の発生を助長する傾向がみられ好ましくない。 (A) A component can mix | blend 1 type (s) or 2 or more types. The blending amount of the component (A) should be appropriately selected according to the specific dosage form of the external preparation for skin and other blending components, and is not particularly limited. Is preferably 0.001 to 20.0% by mass, particularly preferably 0.01 to 10.0% by mass, based on the whole agent. If the amount is less than 0.001% by mass, it is difficult to sufficiently exert the whitening effect. On the other hand, even if the amount exceeds 20.0% by mass, the improvement of the whitening effect commensurate with the increase in the amount is hardly recognized. On the contrary, it tends to promote the generation of a sticky feeling of use, which is not preferable.
本発明における(B)成分としての長鎖アシルスルホン酸塩型陰イオン性界面活性剤は下記一般式(II)で表される。 The long-chain acyl sulfonate type anionic surfactant as the component (B) in the present invention is represented by the following general formula (II).
R1CO−a−(CH2)nSO3M1 (II) R 1 CO-a- (CH 2 ) n SO 3 M 1 (II)
一般式(II)中、R1CO−は平均炭素原子数10〜22の飽和または不飽和の脂肪酸残基(アシル基)を表す。R1COとして、C11H23CO、C12H25CO、C13H27CO、C14H29CO、C15H31CO、C16H33CO、C17H35CO、ココヤシ脂肪酸残基、パームヤシ脂肪酸残基等が例示される。なお、R1COは、安全性等の点から、その平均炭素原子数が12〜22のものがより好ましい。 In the general formula (II), R 1 CO- represents a saturated or unsaturated fatty acid residue having an average carbon number from 10 to 22 (an acyl group). As R 1 CO, C 11 H 23 CO, C 12 H 25 CO, C 13 H 27 CO, C 14 H 29 CO, C 15 H 31 CO, C 16 H 33 CO, C 17 H 35 CO, coconut fatty acid residue Groups, palm palm fatty acid residues and the like. R 1 CO is more preferably one having an average carbon atom number of 12 to 22 from the viewpoint of safety and the like.
aは−O−または−NR2−(ただし、R2は水素原子、または炭素原子数1〜3のアルキル基を示す)を表す。これらは電子供与性基である。aとしては、−O−、−NH−、−N(CH3)−が好ましい。 a represents —O— or —NR 2 — (wherein R 2 represents a hydrogen atom or an alkyl group having 1 to 3 carbon atoms). These are electron donating groups. a is preferably —O—, —NH—, or —N (CH 3 ) —.
M1は水素原子、アルカリ金属類、アルカリ土類金属類、アンモニウムまたは有機アミン類を表す。M1として、例えばリチウム、カリウム、ナトリウム、カルシウム、マグネシウム、アンモニウム、モノエタノールアミン、ジエタノールアミン、トリエタノールアミン、タウリンナトリウム、N−メチルタウリンナトリウム等が挙げられる。 M 1 represents a hydrogen atom, an alkali metal, an alkaline earth metal, ammonium or an organic amine. Examples of M 1 include lithium, potassium, sodium, calcium, magnesium, ammonium, monoethanolamine, diethanolamine, triethanolamine, sodium taurine, sodium N-methyltaurine, and the like.
nは1〜3の整数を表す。 n represents an integer of 1 to 3.
(B)成分として、上記一般式(II)中、aが−O−を示す化合物、すなわち長鎖アシルイセチオン酸塩型陰イオン性界面活性剤としては、ココイルイセチオン酸塩、ステアロイルイセチオン酸塩、ラウリルイセチオン酸塩、ミリストイルイセチオン酸塩等が例示される。 As the component (B), a compound in which a represents —O— in the above general formula (II), that is, as a long-chain acyl isethionate type anionic surfactant, cocoyl isethionate, stearoyl isethionate , Lauryl isethionate, myristoyl isethionate and the like.
上記一般式(II)中、aが−NH−を示す化合物、すなわち長鎖アシルタウリン塩型陰イオン性界面活性剤としては、N−ラウロイルタウリン塩、N−ココイル−N−エタノールタウリン塩、N−ミリストイルタウリン塩、N−ステアロイルタウリン塩等が例示される。 In the general formula (II), a compound in which a represents —NH—, that is, a long-chain acyl taurine salt type anionic surfactant includes N-lauroyl taurine salt, N-cocoyl-N-ethanol taurine salt, N -Myristoyl taurine salt, N-stearoyl taurine salt and the like are exemplified.
上記一般式(II)中、aが−N(CH3)−を示す化合物、すなわち長鎖アシルメチルタウリン塩型陰イオン性界面活性剤としては、N−ラウロイル−N−メチルタウリン塩、N−パルミトイル−N−メチルタウリン塩、N−ステアロイル−N−メチルタウリン塩、N−ココイル−N−メチルタウリン塩等が例示される。 In the above general formula (II), a compound in which a represents —N (CH 3 ) —, ie, a long-chain acylmethyl taurine salt type anionic surfactant, includes N-lauroyl-N-methyl taurate, N— Examples include palmitoyl-N-methyltaurine salt, N-stearoyl-N-methyltaurine salt, N-cocoyl-N-methyltaurine salt and the like.
中でも、(B)成分として、N−ステアロイル−N−メチルタウリン塩が特に好ましい。(B)成分は1種または2種以上を用いることができる。 Among these, N-stearoyl-N-methyltaurine salt is particularly preferable as the component (B). (B) component can use 1 type (s) or 2 or more types.
(C)成分は(C 1 )成分と(C 2 )成分からなる。(C 1 )成分は、ステアリルアルコールおよび/またはベヘニルアルコールである。(C 2 )成分としての高級脂肪族アルコールは、直鎖または分岐鎖のアルキル鎖を有する、炭素原子数12〜22の脂肪族アルコールである。(C)成分としては、例えばラウリルアルコール、セチルアルコール、ステアリルアルコール、ベヘニルアルコール、ミリスチルアルコール、オレイルアルコール、セトステアリルアルコール、硬化ナタネ油アルコール、ホホバアルコール等の直鎖アルコールや、モノステアリルグリセリンエーテル(バチルアルコール)、2−デシルテトラデシノール、ラノリンアルコール、コレステロール、フィトステロール、ヘキシルドデカノール、イソステアリルアルコール、オクチルドデカノール等の分岐鎖アルコールなどが挙げられる。本発明では直鎖アルコールが好ましい。(C 2 )成分は1種または2種以上を用いることができる。 The component (C) is composed of a component (C 1 ) and a component (C 2 ). The component (C 1 ) is stearyl alcohol and / or behenyl alcohol. Higher aliphatic alcohols as (C 2) component has a straight or branched alkyl chain, an aliphatic alcohol having a carbon number of 12 to 22. Examples of the component (C) include linear alcohols such as lauryl alcohol, cetyl alcohol, stearyl alcohol, behenyl alcohol, myristyl alcohol, oleyl alcohol, cetostearyl alcohol, hardened rapeseed oil alcohol, jojoba alcohol, and monostearyl glycerol ether (batyl alcohol). ), 2-decyltetradecinol, lanolin alcohol, cholesterol, phytosterol, hexyldodecanol, isostearyl alcohol, octyldodecanol and other branched chain alcohols. In the present invention, a linear alcohol is preferred. (C 2) component Ru can be used either alone or in combination.
(C)成分は、後述するゲルを形成するに十分な量で、かつ、余剰分を特定量系中に含有するよう、配合される。 (C) A component is mix | blended so that it may be sufficient quantity to form the gel mentioned later and a surplus may be contained in a specific quantity system.
本発明で用いられる(D)成分としての水は、外相をなす。本発明に配合される(D)成分の配合量は、製品に応じて適宜決定されるが、本発明水中油型乳化組成物全量に対して40〜95質量%が好ましい。 Water as the component (D) used in the present invention forms an outer phase. Although the compounding quantity of (D) component mix | blended with this invention is suitably determined according to a product, 40-95 mass% is preferable with respect to this invention oil-in-water emulsion composition whole quantity.
本発明では、上記(B)成分、(C)成分および(D)とでゲルを形成する。このゲルの転移温度が60℃以上となるような組合せとすることが必要であり、より好ましくは転移温度65℃以上である。このゲルの転移温度が60℃未満であると、系の温度安定性が低下し、高温でクリーミングを起すおそれがあり、好ましくない。ゲル形成には(C 1 )成分としてステアリルアルコールおよび/またはベヘニルアルコールが関与する。 In the present invention, a gel is formed with the component (B), the component (C) and the component (D). It is necessary that the gel has a transition temperature of 60 ° C. or higher, more preferably a transition temperature of 65 ° C. or higher. When the gel transition temperature is less than 60 ° C., the temperature stability of the system is lowered, and creaming may occur at a high temperature, which is not preferable. In the gel formation, stearyl alcohol and / or behenyl alcohol are involved as the (C 1 ) component.
なおこのゲルはα−ゲルで構成される。α−ゲルとは、高級脂肪族アルコールと親水性界面活性剤が水中で形成する会合体であって、α−構造(福島正二著「セチルアルコールの物理化学」、フレグランスジャーナル社、1992年)をとるゲルを意味する。 This gel is composed of α-gel. An α-gel is an aggregate formed in water by a higher aliphatic alcohol and a hydrophilic surfactant. The α-structure (Shoji Fukushima, “Physical Chemistry of Cetyl Alcohol”, Fragrance Journal, 1992) Means a gel to take.
上記ゲルを形成する(B)成分の配合量は、水中油型乳化組成物全量に対して0.1質量%以上、1.0質量%未満であることが必要である。0.1質量%未満では、系の温度安定性が低下し、クリーミングを起すおそれがあり、一方、1.0質量%以上では塗布中の使用感が重く、満足できる使用性のものが得られない。 The blending amount of the component (B) that forms the gel needs to be 0.1% by mass or more and less than 1.0% by mass with respect to the total amount of the oil-in-water emulsion composition. If it is less than 0.1% by mass, the temperature stability of the system may be lowered and creaming may occur. On the other hand, if it is 1.0% by mass or more, the feeling during use is heavy and satisfactory usability is obtained. Absent.
また上記ゲルにおいて、ゲルを形成する(B)成分と(C)成分の配合比は、モル比で1:3である。 Moreover, in the said gel, the compounding ratio of (B) component which forms a gel, and (C) component is 1: 3 by molar ratio.
本発明において、ゲルとは水相において形成された(B)成分と(C)成分のラメラ構造からなる会合体を意味している。(B)成分と(C)成分とが会合体を形成していることは、DSC(示差走査熱量測定器)により確認することができる。すなわち(B)成分と(C)成分の両者を混合し、水に分散した試料の吸熱ピークは、(B)成分、(C)成分それぞれを単独に水に溶解または分散した試料で得られる吸熱ピークよりも高温側に単一の吸熱ピークを示すが、(C)成分組成比が低い((C)成分が不足している)場合は、会合体の吸熱ピークの温度は低く、その温度は(C)成分の組成比の増大とともに上昇し、会合体構造が完成された後、(C)成分が過剰になると一定になり、過剰な(C)成分のピークが出現する。 In the present invention, the gel means an aggregate comprising a lamellar structure of the component (B) and the component (C) formed in the aqueous phase. It can be confirmed by DSC (differential scanning calorimeter) that the component (B) and the component (C) form an aggregate. That is, the endothermic peak of the sample in which both the component (B) and the component (C) are mixed and dispersed in water is the endothermic peak obtained in the sample in which the components (B) and (C) are each dissolved or dispersed in water alone. A single endothermic peak is shown on the higher temperature side than the peak, but when the component ratio of component (C) is low (component (C) is insufficient), the temperature of the endothermic peak of the aggregate is low, and the temperature is After the composition ratio of the component (C) increases and the aggregate structure is completed, when the component (C) becomes excessive, it becomes constant and an excessive peak of the component (C) appears.
ここで、会合体構造が完成される組成は、単一のアルキル鎖をもつ親水性界面活性剤と単一のアルキル鎖をもつ高級アルコールで会合体を形成する場合は、親水性界面活性剤1モルに対して高級アルコール3モルであることが知られている。本発明においては、さらに、上記ゲルの形成に関与しない過剰の(C)成分(以下、「(C2)成分」とも記す)、または両親媒性物質を含有し、その含有量は水中油型乳化組成物全量に対して0.5〜10質量%である。 Here, when the aggregate is formed by a hydrophilic surfactant having a single alkyl chain and a higher alcohol having a single alkyl chain, the composition with which the aggregate structure is completed is hydrophilic surfactant 1 It is known that there are 3 moles of higher alcohol per mole. In the present invention, it further contains an excess (C) component (hereinafter also referred to as “(C 2 ) component”) that is not involved in the formation of the gel, or an amphiphile, and the content thereof is an oil-in-water type. It is 0.5-10 mass% with respect to the emulsion composition whole quantity.
ゲルの形成に関与しない(C2)成分の説明は、上記ゲルの形成に関与する(C)成分(以下、「(C1)成分」とも記す)の説明と同じである。通常は、C1成分と同一のC2成分が過剰に添加される。すなわち、ゲルを形成する(B)成分と(C1)成分の配合モル比は1:3であるので、α−ゲル形成に関与する(C1)成分の含有量は、(B)成分のモル数を3倍にした数字に、(C1)成分の平均分子量を乗じた値となる。したがって、この値よりも大きい過剰の(C2)成分が配合され、過剰分が水中油型乳化組成物全量に対して0.5〜10質量%でなければならない。本発明では特に該過剰分を0.98745〜3.50841質量%とする。 Description of involved such have (C 2) component in the formation of the gel is involved in the formation of the gel component (C) (hereinafter, also referred to as "(C 1) component") is the same as described. Usually, the same C 2 component as the C 1 component is added in excess. That is, since the blending molar ratio of the component (B) and the component (C 1 ) forming the gel is 1: 3, the content of the component (C 1 ) involved in α-gel formation is the amount of the component (B). It is a value obtained by multiplying the number obtained by multiplying the number of moles by 3 by the average molecular weight of the component (C 1 ). Therefore, this is greater than the value excess (C 2) component is blended, excess must be 0.5 to 10 mass% relative to oil-in-water emulsion composition the total amount. In the present invention, the excess is particularly set to 0.98745 to 3.50841% by mass.
(C2)成分以外の両親媒性物質が配合されてもよく、好ましくはその融点が55℃以上、さらに好ましくは60℃以上の両親媒性物質である。この融点が55℃未満であると、処方によっては系の温度安定性が低下し、クリーミングを起す場合がある。 An amphiphilic substance other than the component (C 2 ) may be blended, preferably an amphiphilic substance having a melting point of 55 ° C. or higher, more preferably 60 ° C. or higher. When this melting point is less than 55 ° C., the temperature stability of the system is lowered depending on the formulation, and creaming may occur.
本発明において両親媒性物質とは、(C)成分以外の物質であって、界面活性を有するがそれ自体は疎水性が強く一般の界面活性剤ほど界面活性を有さないものであり、例えば高級脂肪酸、モノグリセリド、グリセロールモノアルキルエーテル、モノアルキルアミン、およびステロール類等が挙げられる。具体例としては、ラウリン酸、ミリスチン酸、パルミチン酸、ステアリン酸、ベヘン(ベヘニン)酸、オレイン酸、12−ヒドロキシステアリン酸、ウンデシレン酸、トール酸、イソステアリン酸、リノール酸、リノレイン酸、エイコサペンタエン酸(EPA)、ドコサヘキサエン酸(DHA)等の高級脂肪酸;コレステロール、フィトステロールなどのステロール類;モノグリセリド、グリセロールモノアルキルエーテル、モノアルキルアミン等が挙げられるが、これら例示に限定されるものでない。ゲルの形成に関与しない(C2)成分と両親媒性物質の両方が配合される場合は、両者の合計配合量が水中油型乳化組成物全量に対して0.5〜10質量%となるようにする。本発明では特に該配合量を0.98745〜3.50841質量%とする。
In the present invention, the amphiphilic substance is a substance other than the component (C) and has a surface activity, but itself has a strong hydrophobicity and does not have a surface activity as a general surfactant. Examples include higher fatty acids, monoglycerides, glycerol monoalkyl ethers, monoalkylamines, and sterols. Specific examples include lauric acid, myristic acid, palmitic acid, stearic acid, behenic acid, oleic acid, 12-hydroxystearic acid, undecylenic acid, tolic acid, isostearic acid, linoleic acid, linolenic acid, eicosapentaenoic acid. (EPA), higher fatty acids such as docosahexaenoic acid (DHA); sterols such as cholesterol and phytosterol; monoglyceride, glycerol monoalkyl ether, monoalkylamine and the like, but are not limited to these examples. When both the (C 2 ) component and the amphiphilic substance not involved in gel formation are blended, the total blended amount of both is 0.5 to 10% by mass with respect to the total amount of the oil-in-water emulsion composition. Like that. In the present invention, the blending amount is particularly 0.98745 to 3.50841% by mass.
ゲル形成に関与しない(C2)成分の配合量((C2)成分以外の両親媒性物質を配合する場合は、両者の合計配合量)が0.5質量%未満では、過剰な(C2)成分または両親媒性物質の結晶の量が少なく、十分に高温安定性を維持できない。また配合量が10質量%超では、組成によっては硬度が高くなりすぎ、使用感も悪くなる。 If the blending amount of the (C 2 ) component not involved in gel formation (the total blending amount of both components when blending an amphiphilic substance other than the (C 2 ) component) is less than 0.5% by mass, excessive (C 2 ) The amount of crystals of the component or amphiphile is small, and sufficient high temperature stability cannot be maintained. On the other hand, if the blending amount is more than 10% by mass, the hardness becomes too high depending on the composition, and the feeling in use becomes worse.
本発明においては、ゲルを形成する上記必須成分の(B)成分の他に、新油性非イオン性界面活性剤、陽イオン系界面活性剤、アニオン系界面活性剤、または両性界面活性剤を本発明の効果を損なわない限り配合することができる。なお、ゲルの形成に関与しない(B)成分が存在していてもよい。 In the present invention, in addition to the essential component (B) that forms a gel, a new oily nonionic surfactant, a cationic surfactant, an anionic surfactant, or an amphoteric surfactant is added. As long as the effects of the invention are not impaired, they can be blended. In addition, the (B) component which does not participate in formation of a gel may exist.
本発明の水中油型乳化組成物に配合される(E)成分としての油分は、一般に化粧品に用いられているものの中から安定性を損なわない範囲で選ぶことができる。 The oil as the component (E) blended in the oil-in-water emulsion composition of the present invention can be selected from those generally used in cosmetics within a range not impairing stability.
望ましい油分としては、炭化水素油分などの無極性油分あるいはシリコーン油が好ましい。無極性油分とは分子構造中にエーテル結合、エステル結合、アミド結合、水酸基、カルボキシル基等の水和性の官能基を含まないことを意味している。 Desirable oils are preferably nonpolar oils such as hydrocarbon oils or silicone oils. Nonpolar oil means that the molecular structure does not contain hydratable functional groups such as ether bonds, ester bonds, amide bonds, hydroxyl groups, and carboxyl groups.
炭化水素油としては、流動パラフィン、スクワラン、スクワレン、パラフィン、イソパラフィン、セレシン等が使用できる。 As the hydrocarbon oil, liquid paraffin, squalane, squalene, paraffin, isoparaffin, ceresin and the like can be used.
シリコーン油としては、例えばジメチルポリシロキサン、メチルフェニルポリシロキサン、メチルハイドロジェンポリシロキサン等の鎖状シリコーン;オクタメチルシクロテトラシロキサン、デカメチルシクロペンタシロキサン、ドデカメチルシクロヘキサシロキサン等の環状シリコーン;3次元網目構造を形成しているシリコ−ン樹脂、シリコーンゴムなどが例示される。 Examples of the silicone oil include chain silicones such as dimethylpolysiloxane, methylphenylpolysiloxane, and methylhydrogenpolysiloxane; cyclic silicones such as octamethylcyclotetrasiloxane, decamethylcyclopentasiloxane, and dodecamethylcyclohexasiloxane; Examples thereof include silicone resin and silicone rubber forming a network structure.
極性の油分については、安定性を損なわない範囲で少量を配合することができる。極性油としては液体油脂とエステル油が挙げられる。 About a polar oil component, a small amount can be mix | blended in the range which does not impair stability. Polar oils include liquid oils and ester oils.
液体油脂としては、アマニ油、ツバキ油、マカデミアナッツ油、トウモロコシ油、ミンク油、オリーブ油、アボガド油、サザンカ油、ヒマシ油、サフラワー油、ホホバ油、ヒマワリ油、アルモンド油、ナタネ油、ゴマ油、大豆油、落花生油、トリグリセリン、トリオクタン酸グリセリン、トリイソパルミチン酸グリセリン等がある。 Liquid oils include linseed oil, camellia oil, macadamia nut oil, corn oil, mink oil, olive oil, avocado oil, sasanqua oil, castor oil, safflower oil, jojoba oil, sunflower oil, almond oil, rapeseed oil, sesame oil, large There are bean oil, peanut oil, triglycerin, glycerin trioctanoate, glycerin triisopalmitate and the like.
エステル油としては、オクタン酸セチル、ラウリン酸ヘキシル、ミリスチン酸イソプロピル、パルミチン酸オクチル、ステアリン酸イソセチル、イソステアリン酸イソプロピル、イソパルミチン酸オクチル、オレイン酸イソデシル、トリ2−エチルヘキサン酸グリセリル、テトラ2−エチルヘキサン酸ペンタエリスリット、コハク酸2−エチルヘキシル、セバシン酸ジエチル等がある。 Ester oils include cetyl octanoate, hexyl laurate, isopropyl myristate, octyl palmitate, isocetyl stearate, isopropyl isostearate, octyl isopalmitate, isodecyl oleate, glyceryl tri-2-ethylhexanoate, tetra-2-ethyl There are pentaerythritol hexanoate, 2-ethylhexyl succinate, diethyl sebacate and the like.
(E)成分の配合量は、製品に応じて適宜決定されるが、水中油型乳化組成物全量に対して3〜50質量%であるのが好ましい。なお本発明において(E)成分とは、上記必須成分の(C)成分および両親媒性物質は含まない。 (E) Although the compounding quantity of a component is suitably determined according to a product, it is preferable that it is 3-50 mass% with respect to the oil-in-water type emulsion composition whole quantity. In the present invention, the component (E) does not include the component (C) which is an essential component and an amphiphilic substance.
上記必須成分を含有する本発明は、水中油型乳化組成物において、(B)成分−(C)成分−(D)成分で構成されるゲルを形成するが、配合される(B)成分が乳化組成物全量に対して1質量%未満であるため、ゲルの形成量が少なく、従来の乳液若しくはクリームに比してさっぱりして軽い使用感を有する。また、ゲルとともに、過剰の高融点の(C)成分の結晶を共存させているため、ゲルが少ないにもかかわらず、十分に増粘固化し、クリーミングを防ぐことが可能である。本発明により、配合される界面活性剤が少量であるにもかかわらず、経時安定性が良好で、かつ、使用性も良好な水中油型乳化組成物を提供することが可能である。 In the oil-in-water emulsion composition, the present invention containing the essential components forms a gel composed of (B) component- (C) component- (D) component. Since it is less than 1% by mass with respect to the total amount of the emulsified composition, the amount of gel formation is small, and it has a refreshing and light usability compared to conventional emulsions or creams. In addition, since an excessively high melting point (C) component crystal coexists with the gel, it is possible to sufficiently thicken and solidify and prevent creaming even though the gel is small. According to the present invention, it is possible to provide an oil-in-water emulsion composition having good stability over time and good usability despite a small amount of surfactant to be blended.
本発明の水中油型乳化組成物は、常法により、おもに化粧料、医薬品、医薬部外品等の皮膚外用剤として用いられる水中油型乳化組成物を製造できるが、特に系中にゲルを形成する水中油型クリーム状の剤型を原則としてとる皮膚外用剤として利用されることが好ましい。皮膚外用剤においては、具体的な目的に応じて、本発明の所期の効果を損なわない限りにおいて、一般的な薬効成分や薬剤成分を配合することができる。 The oil-in-water emulsified composition of the present invention can produce oil-in-water emulsified compositions mainly used as a skin external preparation for cosmetics, pharmaceuticals, quasi-drugs and the like by a conventional method. It is preferably used as an external preparation for skin which takes the form of an oil-in-water cream form to be formed in principle. In the external preparation for skin, general medicinal components and drug components can be blended depending on the specific purpose as long as the intended effects of the present invention are not impaired.
薬効成分としては、例えば、本発明皮膚外用剤をサンケア製品として用いる場合には、パラミノ安息香酸等の安息香酸系紫外線吸収剤;アントラニル酸メチル等のアントラニル酸系紫外線吸収剤;サリチル酸オクチル、サリチル酸フェニル、サリチル酸ホモメンチル等のサリチル酸系紫外線吸収剤;パラメトキシケイ皮酸イソプロピル、パラメトキシケイ皮酸オクチル、パラメトキシケイ皮酸−2−エチルヘキシル、ジパラメトキシケイ皮酸モノ−2−エチルヘキサン酸グリセリル、〔4−ビス(トリメチルシロキサン)メチルシリル−3−メチルブチル〕−3,4,5−トリメトキシケイ皮酸エステル等のケイ皮酸系紫外線吸収剤;2,4−ジヒドロキシベンゾフェノン、2−ヒドロキシ−4−メトキシベンゾフェノン、2−ヒドロキシ−4−メトキシベンゾフェノン−5−スルホン酸、2−ヒドロキシ−4−メトキシベンゾフェノン−5−スルホン酸ナトリウム等のベンゾフェノン系紫外線吸収剤;ウロカニン酸、ウロカニン酸エチル、2−フェニル−5−メチルベンゾオキサゾール、2−(2’−ヒドロキシ−5’−メチルフェニル)ベンゾトリアゾール、4−tert−ブチル−4’−メトキシジベンゾイルメタン等の紫外線吸収剤を本発明皮膚外用剤に配合することができる。 As the medicinal component, for example, when the skin external preparation of the present invention is used as a suncare product, a benzoic acid-based ultraviolet absorber such as paraminobenzoic acid; an anthranilic acid-based ultraviolet absorber such as methyl anthranilate; , Salicylic acid UV absorbers such as homomenthyl salicylate; isopropyl paramethoxycinnamate, octyl paramethoxycinnamate, 2-ethylhexyl paramethoxycinnamate, glyceryl mono-2-ethylhexanoate diparamethoxycinnamate, [4-bis (trimethylsiloxane) methylsilyl-3-methylbutyl] -cinnamic acid-based UV absorbers such as 3,4,5-trimethoxycinnamic acid ester; 2,4-dihydroxybenzophenone, 2-hydroxy-4- Methoxybenzophenone, 2-hydroxy- Benzophenone ultraviolet absorbers such as methoxybenzophenone-5-sulfonic acid, sodium 2-hydroxy-4-methoxybenzophenone-5-sulfonate; urocanic acid, ethyl urocanate, 2-phenyl-5-methylbenzoxazole, 2- Ultraviolet absorbers such as (2′-hydroxy-5′-methylphenyl) benzotriazole and 4-tert-butyl-4′-methoxydibenzoylmethane can be blended in the skin external preparation of the present invention.
また保湿効果を本発明皮膚外用剤に付与するために、ポリエチレングリコール、プロピレングリコール、ジプロピレングリコール、グリセリン、ジグリセリン、1,3−ブチレングリコール、ヘキシレングリコール、キシリトール、ソルビトール、マルチトール、マルトース、D−マンニット、水アメ、ブドウ糖、果糖、乳糖、コンドロイチン硫酸ナトリウム、ヒアルロン酸ナトリウム、アデノシンリン酸ナトリウム、乳酸ナトリウム、胆汁酸塩、ピロリドンカルボン酸、グルコサミン、シクロデキストリン等の保湿剤を配合することができる。 In order to impart a moisturizing effect to the skin external preparation of the present invention, polyethylene glycol, propylene glycol, dipropylene glycol, glycerin, diglycerin, 1,3-butylene glycol, hexylene glycol, xylitol, sorbitol, maltitol, maltose, D-mannit, water candy, glucose, fructose, lactose, sodium chondroitin sulfate, sodium hyaluronate, sodium adenosine phosphate, sodium lactate, bile salt, pyrrolidone carboxylic acid, glucosamine, cyclodextrin, etc. Can do.
さらに薬効成分として、油溶性抗酸化剤以外の用途を有するビタミン類;エストラジオール、エチニルエストラジオール等のホルモン類;アルギニン、アスパラギン酸、シスチン、システイン、メチオニン、セリン、ロイシン、トリプトファン等のアミノ酸類;アラントイン、アズレン、グリチルレチン酸等の抗炎症剤;アルブチン等の美白剤;酸化亜鉛、タンニン酸等の収斂剤;L−メントール、カンフル等の清涼剤;イオウ、塩化リゾチーム、塩酸ピリドキシン、γ−オリザノール等を配合することができる。 Further, as medicinal ingredients, vitamins having uses other than oil-soluble antioxidants; hormones such as estradiol and ethinyl estradiol; amino acids such as arginine, aspartic acid, cystine, cysteine, methionine, serine, leucine, and tryptophan; allantoin, Anti-inflammatory agents such as azulene and glycyrrhetinic acid; whitening agents such as arbutin; astringents such as zinc oxide and tannic acid; refreshing agents such as L-menthol and camphor; combined with sulfur, lysozyme chloride, pyridoxine hydrochloride, γ-oryzanol can do.
さらに、多様な薬効を有する各種の抽出物を配合することができる。すなわち、ドクダミエキス、オウバクエキス、メリロートエキス、オドリコソウエキス、カンゾウエキス、シャクヤクエキス、サボンソウエキス、ヘチマエキス、キナエキス、ユキノシタエキス、クララエキス、コウホネエキス、ウイキョウエキス、サクラソウエキス、バラエキス、ジオウエキス、レモンエキス、シコンエキス、アロエエキス、ショウブ根エキス、ユーカリエキス、スギナエキス、セージエキス、タイムエキス、茶エキス、海草エキス、キューカンバーエキス、チョウジエキス、キイチゴエキス、メリッサエキス、ニンジンエキス、マロニエエキス、モモエキス、桃葉エキス、クワエキス、ヤグルマギクエキス、ハマメリエキス、プラセンタエキス、胸腺抽出物、シルク抽出物等を本発明皮膚外用剤中に配合することができる。 Furthermore, various extracts having various medicinal effects can be blended. In other words, Dokudami Extract, Oat Extract, Merilot Extract, Oyster Extract, Licorice Extract, Peonies Extract, Soap Extract, Loofah Extract, Kina Extract, Yukinoshita Extract, Clara Extract, Licorice Extract, Fennel Extract, Primrose Extract, Rose Extract, Giant Extract, Lemon Extract , Sicon extract, aloe extract, ginger root extract, eucalyptus extract, horsetail extract, sage extract, thyme extract, tea extract, seaweed extract, cucumber extract, clove extract, raspberry extract, melissa extract, carrot extract, maroni extract, peach extract, peach leaf extract , Mulberry extract, cornflower extract, clam extract, placenta extract, thymus extract, silk extract, etc. can be blended in the skin external preparation of the present invention. .
なお、これらの薬効成分に、本発明の皮膚外用剤に配合可能な薬効成分が限定されるものでない。また、上記した薬効成分は、単独で本発明皮膚外用剤に配合することの他に、2種類以上の上記薬効成分を、目的に応じ、適宜組合せて配合することも可能である。 In addition, the medicinal component which can be mix | blended with the skin external preparation of this invention is not limited to these medicinal components. Moreover, the above-mentioned medicinal ingredients can be blended as appropriate in combination with two or more kinds of the medicinal ingredients, depending on the purpose, in addition to blending alone with the skin external preparation of the present invention.
本発明の基剤成分としては、上記必須成分の他に、具体的に所望する形態に応じて、公知の基剤成分を、本発明の効果を損なわない範囲で配合できる。 As the base component of the present invention, in addition to the above essential components, a known base component can be blended in a range not impairing the effects of the present invention, depending on the specifically desired form.
例えば、エタノール、プロパノール、イソプロパノール等の低級アルコール;コレステロール、シトステロール、フィトステロール、ラノステロール等のステロール類を本発明皮膚外用剤中に配合することができる。 For example, lower alcohols such as ethanol, propanol, and isopropanol; and sterols such as cholesterol, sitosterol, phytosterol, and lanosterol can be blended in the skin external preparation of the present invention.
また、アラアビアガム、トラガカントガム、ガラクタン、グアガム、キャロブガム、カラヤガム、カラギーナン、ペクチン、寒天、クインスシード(マルメロ)、アルゲコロイド(カッソウエキス)、デンプン(コメ、トウモロコシ、バレイショ、コムギ)、グリチルリチン酸等の植物系水溶性高分子;キサンタンガム、デキストラン、サクシノグルカン、ブルラン等の微生物系水溶性高分子;コラーゲン、カゼイン、アルブミン、ゼラチン等の動物系水溶性高分子;カルボキシメチルデンプン、メチルヒドロキシプロピルデンプン等のデンプン系水溶性高分子;メチルセルロース、ニトロセルロース、エチルセルロース、メチルヒドロキシプロピルセルロース、ヒドロキシエチルセルロース、セルロース硫酸ナトリウム、ヒドロキシプロピルセルロース、カルボキシメチルセルロースナトリウム(CMC)、結晶セルロース、セルロース末等のセルロース系水溶性高分子;アルギン酸ナトリウム、アルギン酸プロピレングリコールエステル等のアルギン酸系水溶性高分子;ポリビニルアルコール、ポリビニルメチルエーテル、ポリビニルピロリドン、カルボキシビニルポリマー(カーボポール)等のビニル系水溶性高分子;ポリエチレングリコール20,000、同4,000,000、同600,000等のポリオキシエチレン系水溶性高分子;ポリオキシエチレンポリオキシプロピレン共重合体等の共重合系水溶性高分子;ポリアクリル酸ナトリウム、ポリエチルアクリレート、ポリアクリルアミド等のアクリル系水溶性高分子のほか、ポリエチレンイミン、カチオンポリマーなどが例示される。またベントナイト、ケイ酸AlMg(ビーガム)、ラポナイト、ヘクトライト、無水ケイ酸などの無機の水溶性高分子も挙げられる。 In addition, plant-based water solutions such as arabia gum, tragacanth gum, galactan, guar gum, carob gum, caraya gum, carrageenan, pectin, agar, quince seed (malmello), alge colloid (gypsum extract), starch (rice, corn, potato, wheat), glycyrrhizic acid, etc. Water-soluble polymers such as xanthan gum, dextran, succinoglucan, and bullulan; animal-based water-soluble polymers such as collagen, casein, albumin, and gelatin; starches such as carboxymethyl starch and methylhydroxypropyl starch Water-soluble polymer: methylcellulose, nitrocellulose, ethylcellulose, methylhydroxypropylcellulose, hydroxyethylcellulose, sodium cellulose sulfate, hydroxypropy Cellulose-based water-soluble polymers such as cellulose, sodium carboxymethyl cellulose (CMC), crystalline cellulose, cellulose powder; alginic acid-based water-soluble polymers such as sodium alginate and propylene glycol alginate; polyvinyl alcohol, polyvinyl methyl ether, polyvinyl pyrrolidone, carboxy Vinyl-based water-soluble polymers such as vinyl polymers (Carbopol); Polyoxyethylene-based water-soluble polymers such as polyethylene glycol 20,000, 4,000,000, and 600,000; Polyoxyethylene polyoxypropylene Copolymer water-soluble polymers such as polymers; water-soluble acrylic polymers such as sodium polyacrylate, polyethyl acrylate, polyacrylamide, polyethyleneimine, cationic polymers Etc. are exemplified. In addition, inorganic water-soluble polymers such as bentonite, silicate AlMg (beegum), laponite, hectorite, and silicic anhydride are also included.
さらに、アラニン、エデト酸ナトリウム塩、ポリリン酸ナトリウム、メタリン酸ナトリウム、リン酸等の金属イオン封鎖剤;2−アミノ−2−メチル−1−プロパノール、2−アミノ−2−メチル−1,3−プロパンジオール、水酸化カリウム、水酸化ナトリウム、L−アルギニン、L−リジン、トリエタノールアミン、炭酸ナトリウム等の中和剤;乳酸、クエン酸、グリコール酸、コハク酸、酒石酸、dl−リンゴ酸、炭酸カリウム、炭酸水素ナトリウム、炭酸水素アンモニウム等のpH調整剤等の酸化防止剤を本発明皮膚外用剤中に配合することができる。 Furthermore, sequestering agents such as alanine, sodium edetate, sodium polyphosphate, sodium metaphosphate, phosphoric acid; 2-amino-2-methyl-1-propanol, 2-amino-2-methyl-1,3- Neutralizing agents such as propanediol, potassium hydroxide, sodium hydroxide, L-arginine, L-lysine, triethanolamine, sodium carbonate; lactic acid, citric acid, glycolic acid, succinic acid, tartaric acid, dl-malic acid, carbonic acid Antioxidants such as potassium, sodium hydrogen carbonate, ammonium hydrogen carbonate and other pH adjusters can be blended in the skin external preparation of the present invention.
また、安息香酸、サリチル酸、石炭酸、パラオキシ安息香酸エステル、パラクロルメタクレゾール、ヘキサクロロフェン、塩化ベンザルコニウム、塩化クロルヘキシジン、トリクロロカルバニド、感光素、フェノキシエタノール、パラベン等の抗菌剤等を本発明皮膚外用剤中に配合することができる。 In addition, antibacterial agents such as benzoic acid, salicylic acid, coalic acid, paraoxybenzoic acid ester, parachloromethcresol, hexachlorophene, benzalkonium chloride, chlorhexidine chloride, trichlorocarbanide, photosensitizer, phenoxyethanol, paraben, etc. It can mix | blend in an agent.
また、必要に応じて適当な香料、色素等を本発明の所期の効果を損なわない範囲で本発明皮膚外用剤に配合することができる。 Moreover, a suitable fragrance | flavor, pigment | dye, etc. can be mix | blended with this invention skin external preparation in the range which does not impair the effect of this invention as needed.
なお上記の基剤成分は例示であり、これらの基剤成分に本発明皮膚外用剤に配合可能な基剤成分が限定されるものではない。 In addition, said base component is an illustration and the base component which can be mix | blended with these base components in this invention external preparation is not limited.
これらの基剤成分は所望する形態に応じた処方に従い、適宜組み合わせて本発明皮膚外用剤に配合することができる。 These base components can be appropriately combined and blended in the skin external preparation of the present invention according to a prescription according to a desired form.
本発明について以下に実施例を挙げてさらに詳述するが、本発明はこれによりなんら限定されるものではない。配合量は特記しない限り、その成分が配合される系に対する質量%で示す。 The present invention will be described in more detail with reference to the following examples, but the present invention is not limited thereto. Unless otherwise specified, the blending amount is expressed in mass% with respect to the system in which the component is blended.
(実施例1〜4、比較例1〜4)
下記表1に示す実施例、比較例の組成物を有する水中油型乳化組成物を調製し、これを試料として、下記評価基準に従って、経時安定性、使用性の評価を行った。結果を併せて表1に示す。
(Examples 1-4, Comparative Examples 1-4)
The oil-in-water emulsion compositions having the compositions of Examples and Comparative Examples shown in the following Table 1 were prepared, and the stability with time and usability were evaluated according to the following evaluation criteria using this as a sample. The results are also shown in Table 1.
(実施例5〜7、比較例5〜7)
下記表2に示す実施例、比較例の組成物を有する水中油型乳化組成物を調製し、これを試料として、下記評価基準に従って、経時安定性、使用性の評価を行った。結果を併せて表2に示す。
(Examples 5-7, Comparative Examples 5-7)
An oil-in-water emulsion composition having the compositions of Examples and Comparative Examples shown in Table 2 below was prepared, and the stability over time and usability were evaluated according to the following evaluation criteria using this as a sample. The results are also shown in Table 2.
(製法)
表1、2において、処方中の水相成分および油相成分をそれぞれ混合し、80℃の水相に80℃に加温した油相を加え、ホモミキサーで均一に乳化した後、水に溶解した薬剤成分を加えて撹拌し、室温まで冷却して、水中油型乳化組成物を調製した。
(Manufacturing method)
In Tables 1 and 2, the water phase component and the oil phase component in the formulation were mixed, and the oil phase heated to 80 ° C was added to the 80 ° C aqueous phase, and the mixture was uniformly emulsified with a homomixer and dissolved in water. The drug component was added and stirred, and cooled to room temperature to prepare an oil-in-water emulsion composition.
なお表1、2中、「(C)成分のモル数(*1)」、「(B)成分または界面活性剤のモル数(*1)」は、いずれも水中油型乳化組成物100g中に含まれるモル数を示す。 In Tables 1 and 2, “(C) component mole number (* 1) ” and “(B) component or surfactant mole number (* 1) ” are all in 100 g of the oil-in-water emulsion composition. The number of moles contained in is shown.
また、ゲルに関与する(C)成分(質量%)は、(B)成分(比較例では(他の)界面活性剤)のモル数×3×(C)成分の平均分子量で示される。単一の直鎖アルキル鎖をもつ(C)成分と単一の直鎖アルキル鎖の(B)成分(比較例では(他の)界面活性剤)の場合、界面活性剤1モルに対して3モルの(C)成分が会合しゲルを形成することがわかっていることから、計算によりゲルに関与しない(C)成分量を求めることができる。 The component (C) (% by mass) involved in the gel is represented by the number of moles of the component (B) ((other) surfactant in the comparative example) × 3 × (C) average molecular weight. In the case of the component (C) having a single straight chain alkyl chain and the component (B) of a single straight chain alkyl chain ((other) surfactant in the comparative example), 3 parts per mole of the surfactant Since it is known that the mole (C) component associates to form a gel, the amount of the (C) component not involved in the gel can be determined by calculation.
ゲルに関与しない(C)成分=(C)成分の配合量−ゲルに関与する(C)成分配合量。 Component (C) not involved in gel = blending amount of component (C)-blending amount of component (C) involved in gel.
[低温および高温安定性]
各試料を−20℃および50℃にて1ヶ月間保存した後の状態を目視で観察し、下記の基準により評価した。
(評価基準)
○: 状態に全く変化なし
△: 水相の分離がわずかにみられる
×: 水相がかなり分離している
[Low temperature and high temperature stability]
The state after each sample was stored at −20 ° C. and 50 ° C. for 1 month was visually observed and evaluated according to the following criteria.
(Evaluation criteria)
○: No change in state △: Slight separation of aqueous phase is observed ×: Aqueous phase is considerably separated
[使用性]
各資料を以下の基準に従って評価した。
(評価基準)
○: 軽い使用感
△: やや重い使用感
×: 重い使用感
[Usability]
Each material was evaluated according to the following criteria.
(Evaluation criteria)
○: Light use feeling △: Somewhat heavy use feeling ×: Heavy use feeling
(製法)
処方中の水相成分および油相成分をそれぞれ混合し、80℃の水相に80℃に加温した油相を加え、ホモミキサーで均一に乳化した後、水に溶解した薬剤成分を加えて撹拌し、室温まで冷却して、水中油型乳化組成物を調製した。
(Manufacturing method)
Mix the water phase component and oil phase component in the formulation, add the oil phase heated to 80 ° C to the 80 ° C water phase, uniformly emulsify with a homomixer, and then add the drug component dissolved in water. The mixture was stirred and cooled to room temperature to prepare an oil-in-water emulsion composition.
表1において、実施例1〜4および比較例1〜4は(B)成分、(C)成分の配合量について検討した例である。(B)成分および(C)成分の配合量が本発明の要件を満足する実施例1〜4は、低温および高温安定性、使用性が良好であったが、ゲル形成に関与しない過剰な(C)成分の配合量が0.5質量%未満である比較例1は、高温安定性が劣っており、(B)成分の配合量が0.1質量%未満である比較例2は低温および高温安定性に劣り、ゲル形成に関与しない過剰な(C)成分の配合量が10質量%を超えている比較例3、(B)成分の配合量が1.0質量%以上である比較例4は使用性が劣っていた。 In Table 1, Examples 1 to 4 and Comparative Examples 1 to 4 are examples in which the blending amounts of the component (B) and the component (C) were examined. In Examples 1 to 4, in which the blending amounts of the component (B) and the component (C) satisfy the requirements of the present invention, the low-temperature and high-temperature stability and usability were good, but excessive (not involved in gel formation) Comparative Example 1 in which the blending amount of component C) is less than 0.5% by mass is inferior in high-temperature stability, and Comparative Example 2 in which the blending amount of component (B) is less than 0.1% by mass is low temperature and Comparative Example 3 in which the compounding amount of the excess component (C) is inferior to high-temperature stability and does not participate in gel formation exceeds 10% by mass, and the compounding amount of component (B) is 1.0% by mass or more. 4 was inferior in usability.
表2において、本願発明に係る実施例5〜7は、低温安定性、高温安定性、および使用性のいずれにおいても本願発明効果を得ることができた。比較例5は界面活性剤として、(B)成分に代えてN-ステアロイル−L-グルタミン酸モノナトリウムを使用した例であり、比較例6は界面活性剤として、(B)成分に代えてノニオン系界面活性剤のPOE(20)ステアリルエーテルを使用した例であるが、いずれも低温安定性が劣っていた。比較例7はゲルの転移温度が60℃未満となるよう(B)成分−(C)成分−(D)成分の配合処方を設定した例であり、高温安定性が劣っていた。 In Table 2, Examples 5 to 7 according to the present invention were able to obtain the effects of the present invention in any of low temperature stability, high temperature stability, and usability. Comparative Example 5 is an example in which N-stearoyl-L-glutamate monosodium is used as a surfactant instead of the component (B), and Comparative Example 6 is a nonionic surfactant instead of the component (B). In this example, the surfactant POE (20) stearyl ether was used, but in all cases, the low-temperature stability was poor. Comparative Example 7 is an example in which a blending formulation of (B) component- (C) component- (D) component was set so that the gel transition temperature was less than 60 ° C., and the high-temperature stability was poor.
本発明に係る水中油型乳化組成物は、美白効果に優れ、かつ経時安定性および使用性が良好な皮膚外用剤として用いるのに適用される。
The oil-in-water emulsified composition according to the present invention is applied to use as a skin external preparation having excellent whitening effect and good stability over time and usability.
Claims (2)
(A)成分: 下記一般式(I)で示されるアルコキシサリチル酸またはその塩。
(式(I)中、Rは炭素原子数1〜6の低級アルキル基を示す)。
(B)成分: 下記一般式(II)で表される長鎖アシルスルホン酸塩型陰イオン性界面活性剤。
R1CO−a−(CH2)nSO3M1 (II)
(式(II)中、R1CO−は平均炭素原子数10〜22の飽和または不飽和の脂肪酸残基(アシル基)を示し;aは−O−または−NR2−(ただし、R2は水素原子、または炭素原子数1〜3のアルキル基を示す)を示し;M1は水素原子、アルカリ金属類、アルカリ土類金属類、アンモニウムまたは有機アミン類を示し;nは1〜3の整数を示す)。
(C)成分: 下記(C 1 )成分および(C 2 )成分。
(C 1 )成分:ステアリルアルコールおよび/またはベヘニルアルコール。
(C 2 )成分:直鎖または分岐鎖のアルキル鎖を有する、炭素原子数12〜22の高級脂肪族アルコール。
(D)成分: 水。
(E)成分: 油分。
条件(i): (B)成分と(C 1 )成分と(D)成分とでゲルを形成し、形成されるゲルの転移温度が60℃以上である。
条件(ii): 上記ゲルを形成する(B)成分の配合量が、水中油型乳化皮膚外用剤全量に対して0.1質量%以上1.0質量%未満である。
条件(iii): 上記ゲルを形成する(B)成分と(C 1 )成分の配合量のモル比が1:3である。
条件(iv):ゲルの形成に関与しない(C 2 )成分または両親媒性物質を含有し、その配合量が水中油型乳化皮膚外用剤全量に対して0.98745〜3.50841質量%である。 An oil-in-water emulsified skin external preparation containing the following components (A) to (E) and satisfying the following conditions (i) to (iv).
Component (A): Alkoxysalicylic acid represented by the following general formula (I) or a salt thereof.
(In the formula (I), R represents a lower alkyl group having 1 to 6 carbon atoms).
(B) Component: Long chain acyl sulfonate type anionic surfactant represented by the following general formula (II).
R 1 CO-a- (CH 2 ) n SO 3 M 1 (II)
(In the formula (II), R 1 CO— represents a saturated or unsaturated fatty acid residue (acyl group) having an average carbon number of 10 to 22; a represents —O— or —NR 2 — (where R 2 Represents a hydrogen atom or an alkyl group having 1 to 3 carbon atoms); M 1 represents a hydrogen atom, an alkali metal, an alkaline earth metal, ammonium or an organic amine; n represents 1 to 3 Indicates an integer).
(C) component: The following (C 1 ) component and (C 2 ) component.
Component (C 1 ): stearyl alcohol and / or behenyl alcohol.
(C 2) component: with a straight or branched alkyl chain, higher aliphatic alcohols carbon atoms 12 to 22.
(D) Component: Water.
(E) component: Oil content.
Condition (i): (B) forming a component and gel in the (C 1) component and the (D) component transition temperature of the gel formed is 60 ° C. or higher.
Condition (ii): The blending amount of the component (B) forming the gel is 0.1% by mass or more and less than 1.0% by mass with respect to the total amount of the oil-in-water emulsified skin external preparation.
Condition (iii): The molar ratio of the blending amount of the component (B) and the component (C 1 ) forming the gel is 1: 3.
Condition (iv): I do not want to participate in the formation of the gel (C 2) containing components or amphiphile, from 0.98745 to 3.50841 weight amount thereof is against the oil-in-water emulsion total amount of the skin treatment composition %.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2003373589A JP4152301B2 (en) | 2003-10-31 | 2003-10-31 | Oil-in-water emulsion composition |
CNB2004100861933A CN100496448C (en) | 2003-10-31 | 2004-10-26 | Oil-in-water emulsion composition |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2003373589A JP4152301B2 (en) | 2003-10-31 | 2003-10-31 | Oil-in-water emulsion composition |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2005132806A JP2005132806A (en) | 2005-05-26 |
JP4152301B2 true JP4152301B2 (en) | 2008-09-17 |
Family
ID=34649572
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2003373589A Expired - Lifetime JP4152301B2 (en) | 2003-10-31 | 2003-10-31 | Oil-in-water emulsion composition |
Country Status (2)
Country | Link |
---|---|
JP (1) | JP4152301B2 (en) |
CN (1) | CN100496448C (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2452668B1 (en) | 2009-07-06 | 2018-10-03 | Kao Corporation | Emulsified composition |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4968774B2 (en) * | 2006-08-11 | 2012-07-04 | 株式会社 資生堂 | Cream composition |
CN102000009B (en) * | 2010-11-12 | 2012-06-06 | 中国农业科学院油料作物研究所 | Flaxseed oil-containing cleansing cream and preparation method thereof |
US9655821B2 (en) | 2013-04-05 | 2017-05-23 | The Procter & Gamble Company | Personal care composition comprising a pre-emulsified formulation |
US10806688B2 (en) | 2014-10-03 | 2020-10-20 | The Procter And Gamble Company | Method of achieving improved volume and combability using an anti-dandruff personal care composition comprising a pre-emulsified formulation |
US9993404B2 (en) | 2015-01-15 | 2018-06-12 | The Procter & Gamble Company | Translucent hair conditioning composition |
KR20170063385A (en) * | 2015-11-30 | 2017-06-08 | 후지필름 가부시키가이샤 | Oil-in-water emulsion gel composition, external preparation for skin and producing method of oil-in-water emulsion composition |
WO2017127344A1 (en) | 2016-01-20 | 2017-07-27 | The Procter & Gamble Company | Hair conditioning composition comprising monoalkyl glyceryl ether |
CN108309875B (en) * | 2018-05-07 | 2021-03-30 | 广东赛尔生物科技有限公司 | Moisturizing and moisture-preserving face cream and preparation method thereof |
CN115737451A (en) * | 2022-11-17 | 2023-03-07 | 美出莱(杭州)化妆品有限责任公司 | Alpha-gel composition, cosmetic and preparation method thereof |
-
2003
- 2003-10-31 JP JP2003373589A patent/JP4152301B2/en not_active Expired - Lifetime
-
2004
- 2004-10-26 CN CNB2004100861933A patent/CN100496448C/en active Active
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2452668B1 (en) | 2009-07-06 | 2018-10-03 | Kao Corporation | Emulsified composition |
Also Published As
Publication number | Publication date |
---|---|
CN100496448C (en) | 2009-06-10 |
JP2005132806A (en) | 2005-05-26 |
CN1636549A (en) | 2005-07-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6010418B2 (en) | Emulsified composition | |
JP3609834B2 (en) | Skin preparation | |
JP5718010B2 (en) | Oil-in-water emulsion composition | |
US8182827B2 (en) | Oil-in-water emulsion composition | |
JP2008260707A (en) | Water-in-oil emulsion composition | |
JP4226073B2 (en) | Emulsified composition | |
WO2011033858A1 (en) | External preparation for skin | |
JP4152301B2 (en) | Oil-in-water emulsion composition | |
JP3853868B2 (en) | Oil-in-water emulsion composition | |
JPH11199465A (en) | Skin preparation for external use | |
JP3829048B2 (en) | Oil-in-water emulsion composition | |
JP5588164B2 (en) | Oil-in-water emulsified skin cosmetic | |
JP5112673B2 (en) | Ceramide-containing composition and external preparation for skin containing the same | |
JPH0987130A (en) | Emulsified composition | |
JP2012036119A (en) | Oil-in-water-type emulsified composition | |
JP2012001497A (en) | Oil-in-water emulsion composition | |
JP3829049B2 (en) | Oil-in-water emulsion composition | |
JP3447177B2 (en) | Gel composition | |
JPH08245357A (en) | Cosmetic | |
JPH10279417A (en) | Preparation for external use for skin | |
JPH1095706A (en) | Emulsifying agent composition | |
JP3634139B2 (en) | Oil-in-water emulsion composition | |
JPH09263510A (en) | Emulsified composition | |
JP3587320B2 (en) | Emulsion composition | |
JPH08126831A (en) | Emulsion composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20060310 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20070412 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20070419 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20070607 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20080122 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20080324 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20080415 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20080611 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20080701 |
|
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20080701 |
|
R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 Ref document number: 4152301 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110711 Year of fee payment: 3 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120711 Year of fee payment: 4 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130711 Year of fee payment: 5 |
|
EXPY | Cancellation because of completion of term |